<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mma" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mma</book-part-id>
      <title-group>
        <title>Isolated Methylmalonic Acidemia</title>
        <alt-title alt-title-type="alt-title">Synonym: Isolated Methylmalonic Aciduria</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Manoli</surname>
            <given-names>Irini</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Genetics and Molecular Biology Branch<break/>National Human Genome Research Institute <break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>manolii@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sloan</surname>
            <given-names>Jennifer L</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Genetics and Molecular Biology Branch<break/>National Human Genome Research Institute <break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>jsloan@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Venditti</surname>
            <given-names>Charles P</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Genetics and Molecular Biology Branch<break/>National Human Genome Research Institute <break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>venditti@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>16</day>
          <month>8</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>7</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>1</day>
          <month>12</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="kms" document-type="chapter">Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="iso-def" document-type="chapter">Isolated Sulfite Oxidase Deficiency</related-object>
      <abstract id="mma.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Isolated methylmalonic acidemia/aciduria, the topic of this <italic toggle="yes">GeneReview</italic>, is caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (<italic toggle="yes">mut</italic><sup>0</sup> enzymatic subtype or <italic toggle="yes">mut</italic><sup>&#x02013;</sup> enzymatic subtype, respectively), a defect in the transport or synthesis of its cofactor, adenosyl-cobalamin (<italic toggle="yes">cblA</italic>, <italic toggle="yes">cblB</italic>, or <italic toggle="yes">cblD</italic>-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. Onset of the manifestations of isolated methylmalonic acidemia/aciduria ranges from the neonatal period to adulthood. All phenotypes are characterized by periods of relative health and intermittent metabolic decompensation, usually associated with intercurrent infections and stress.</p>
          <list list-type="bullet">
            <list-item>
              <p>In the neonatal period the disease can present with lethargy, vomiting, hypotonia, hypothermia, respiratory distress, severe ketoacidosis, hyperammonemia, neutropenia, and thrombocytopenia and can result in death within the first four weeks of life.</p>
            </list-item>
            <list-item>
              <p>In the infantile/non-B<sub>12</sub>-responsive phenotype, infants are normal at birth, but develop lethargy, vomiting, dehydration, failure to thrive, hepatomegaly, hypotonia, and encephalopathy within a few weeks to months of age.</p>
            </list-item>
            <list-item>
              <p>An intermediate B<sub>12</sub>-responsive phenotype can occasionally be observed in neonates, but is usually observed in the first months or years of life; affected children exhibit anorexia, failure to thrive, hypotonia, and developmental delay, and sometimes have protein aversion and/or vomiting and lethargy after protein intake.</p>
            </list-item>
            <list-item>
              <p>Atypical and "benign"/adult methylmalonic acidemia phenotypes are associated with increased, albeit mild, urinary excretion of methylmalonate.</p>
            </list-item>
          </list>
          <p>Major secondary complications of methylmalonic acidemia include: intellectual impairment (variable); tubulointerstitial nephritis with progressive renal failure; &#x0201c;metabolic stroke&#x0201d; (acute and chronic basal ganglia injury) causing a disabling movement disorder with choreoathetosis, dystonia, and para/quadriparesis; pancreatitis; growth failure; functional immune impairment; and optic nerve atrophy.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis of isolated methylmalonic acidemia relies on analysis of organic acids in plasma and/or urine by gas-liquid chromatography and mass spectrometry. Establishing the specific subtype of methylmalonic acidemia requires cellular biochemical studies (including <sup>14</sup>C propionate incorporation and B<sub>12</sub> responsiveness, complementation analysis, and cobalamin distribution assays) and molecular genetic testing. The finding of biallelic pathogenic variants in one of the five genes (<italic toggle="yes">MUT, MMAA</italic>, <italic toggle="yes">MMAB</italic>, <italic toggle="yes">MCEE,</italic> and <italic toggle="yes">MMADHC</italic>) associated with isolated methylmalonic acidemia &#x02013; with confirmation of carrier status in the parents &#x02013; can establish the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Critically ill individuals are stabilized by restoring volume status and acid-base balance; reducing or eliminating protein intake; providing increased calories via high glucose-containing fluids and insulin to arrest catabolism; and monitoring serum electrolytes and ammonia, venous or arterial blood gases, and urine output. Management includes a high-calorie diet low in propiogenic amino acid precursors; hydroxocobalamin intramuscular injections; carnitine supplementation; antibiotics such as neomycin or metronidazole to reduce propionate production from gut flora; gastrostomy tube placement as needed; and aggressive treatment of infections. Other therapies used in a limited number of patients include <italic toggle="yes">N</italic>-carbamylglutamate for the treatment of acute hyperammonemic episodes; liver, kidney, or combined liver and kidney transplantation; and antioxidants for the treatment of optic nerve atrophy.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> In some cases, newborn screening allows for presymptomatic detection of affected newborns and early treatment.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Fasting and increased dietary protein.</p>
          <p><italic toggle="yes">Other:</italic> Medic Alert<sup>&#x000ae;</sup> bracelets and up-to-date, easily accessed, detailed emergency treatment protocols facilitate care.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Isolated methylmalonic acidemia is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible using molecular genetic techniques if the pathogenic variants in the family are known. In some circumstances, prenatal diagnosis for pregnancies at increased risk is possible by enzyme analysis and metabolite measurements on cultured fetal cells (obtained by chorionic villus sampling or amniocentesis).</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mma.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="mma.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mma.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Isolated Methylmalonic Acidemia/Aciduria: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mma.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Complete or partial deficiency of the enzyme methylmalonyl-CoA mutase</p></list-item><list-item><p>Defect in transport or synthesis of the methylmalonyl-CoA mutase cofactor, adenosyl-cobalamin</p></list-item><list-item><p>Deficiency of the enzyme methylmalonyl-CoA epimerase</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="mma.Diagnosis">
        <title>Diagnosis</title>
        <p>For this review, the term "isolated methylmalonic acidemia" refers to a group of inborn errors of metabolism associated with elevated methylmalonic acid (MMA) concentration in the blood and urine that result from the failure to convert methylmalonyl-CoA into succinyl-CoA during propionyl-CoA metabolism in the mitochondrial matrix, without hyperhomocysteinemia or homocystinuria, hypomethioninemia, or variations in other metabolites, such as malonic acid (<xref ref-type="fig" rid="mma.F1">Figure 1</xref>).</p>
        <p>Isolated methylmalonic acidemia results from any ONE of the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete (<italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype) deficiency or partial (<italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype) deficiency of the enzyme methylmalonyl-CoA mutase encoded by <italic toggle="yes">MUT</italic></p>
          </list-item>
          <list-item>
            <p>Diminished synthesis of its cofactor 5'-deoxyadenosylcobalamin, associated with <italic toggle="yes">cblA</italic>, <italic toggle="yes">cblB</italic>, or <italic toggle="yes">cblD-</italic>MMA complementation groups caused by biallelic pathogenic variants in <italic toggle="yes">MMAA, MMAB,</italic> or <italic toggle="yes">MMADHC</italic>, respectively</p>
          </list-item>
          <list-item>
            <p>Deficient activity of methylmalonyl-CoA epimerase encoded by <italic toggle="yes">MCEE</italic></p>
          </list-item>
        </list>
        <p>Note that the following disorders are NOT included in the scope of this <italic toggle="yes">GeneReview</italic> (see <xref ref-type="sec" rid="mma.Differential_Diagnosis">Differential Diagnosis</xref>):</p>
        <list list-type="bullet">
          <list-item>
            <p>Methylmalonic acidemia associated with succinyl-CoA ligase deficiency, caused by mutation of <italic toggle="yes">SUCLA2</italic> or <italic toggle="yes">SUCLG1</italic>, is discussed in <related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</related-object> and <related-object link-type="booklink" source-id="gene" document-id="suclg1-mtddepl" document-type="chapter"><italic toggle="yes">SUCLG1</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</related-object>, respectively.</p>
          </list-item>
          <list-item>
            <p>Methylmalonic acidemia associated with hyperhomocysteinemia or homocystinuria caused by defects in other steps of intracellular cobalamin metabolism is discussed in <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">Disorders of Intracellular Cobalamin Metabolism</related-object>.</p>
          </list-item>
          <list-item>
            <p>Rare defects, such as combined malonic and methylmalonic acidemia, methylmalonate semialdehyde dehydrogenase deficiency, transcobalamin receptor deficiency, and combined methylmalonic acidemia and homocysteinemia, <italic toggle="yes">cblX</italic> type, are discussed briefly under <xref ref-type="sec" rid="mma.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
          </list-item>
        </list>
        <sec id="mma.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Because the presenting signs and symptoms of isolated methylmalonic acidemia are nonspecific, suggestive findings can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>In neonates: lethargy, vomiting, hypotonia, hypothermia, respiratory distress, severe ketoacidosis, hyperammonemia, neutropenia, and thrombocytopenia</p>
              <p>Note: In states with an expanded newborn screening program, isolated methylmalonic acidemia can be diagnosed in well-appearing newborns prior to an episode of acute decompensation.</p>
            </list-item>
            <list-item>
              <p>In older infants and children: failure to thrive, renal syndromes and hypotonia, intellectual disability or other acute (basal ganglia stroke) and chronic neurologic symptoms</p>
            </list-item>
          </list>
          <p>In patients with partial <italic toggle="yes">mut</italic> enzymatic deficiency, <italic toggle="yes">cblA</italic>, or <italic toggle="yes">cblB,</italic> suggestive findings at various ages can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>An attenuated MMA phenotype [<xref ref-type="bibr" rid="mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</xref>, <xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Isolated renal tubular acidosis or chronic renal failure [<xref ref-type="bibr" rid="mma.REF.dudley.1998.564">Dudley et al 1998</xref>, <xref ref-type="bibr" rid="mma.REF.coman.2006.270">Coman et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Metabolic stroke of the basal ganglia [<xref ref-type="bibr" rid="mma.REF.korf.1986.364">Korf et al 1986</xref>, <xref ref-type="bibr" rid="mma.REF.heidenreich.1988.1022">Heidenreich et al 1988</xref>]</p>
            </list-item>
            <list-item>
              <p>Catastrophic/lethal ketoacidosis following an intercurrent illness [<xref ref-type="bibr" rid="mma.REF.ciani.2000.2119">Ciani et al 2000</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="mma.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>An overview of the process of <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">intracellular propionate and cobalamin metabolism</related-object> is depicted in <xref ref-type="fig" rid="mma.F1">Figure 1</xref>. A flowchart for the work up of a person with elevated methylmalonic acid in urine and/or plasma is provided in <xref ref-type="fig" rid="mma.F2">Figure 2</xref>, a modified algorithm that includes the consideration of methylmalonyl-CoA epimerase deficiency, succinyl-CoA ligase deficiency, and other rare defects in the pathway, as well as the use of in vivo vitamin B<sub>12</sub> responsiveness in the work up of an individual who is found to have methylmalonic acidemia at any age.</p>
          <p><bold>Step 1.</bold> In a proband with suspicious clinical findings and a positive urine organic acid screen for MMA, laboratory testing that can help to establish the diagnosis includes: glucose, electrolytes, ammonia, blood gas, lactate, CBC, and urine ketones, plasma MMA, tHcy, and B<sub>12</sub> levels, plasma amino acids, and acylcarnitine profile. Relevant findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>High plasma and urine MMA with normal B<sub>12</sub>, tHcy, and methionine levels</p>
            </list-item>
            <list-item>
              <p>Elevated propionylcarnitine (C3)</p>
            </list-item>
            <list-item>
              <p>High anion gap metabolic acidosis in arterial or venous blood gas testing and huge quantities of ketone bodies and lactate in the urine</p>
            </list-item>
            <list-item>
              <p>Hyperammonemia</p>
            </list-item>
            <list-item>
              <p>Hyperglycinemia</p>
            </list-item>
            <list-item>
              <p>Lactic acidosis</p>
            </list-item>
            <list-item>
              <p>CBC showing neutropenia, thrombocytopenia, anemia</p>
            </list-item>
          </list>
          <p><bold>Step 2.</bold> In newborns found to have elevation of propionylcarnitine (C3) by expanded newborn screening and in individuals at high genetic risk for the disorder (e.g., sibs of a proband), the first priority is to establish the presence of significantly elevated methylmalonic acid, which is best done by urine organic acid analysis (by GC/MS) and plasma acylcarnitine profile (by TMS). Note: At the same time, obtaining levels of plasma MMA, amino acids, plasma homocysteine, and serum vitamin B<sub>12</sub> (in both the newborn and the mother) helps further differentiate the cause of methylmalonic acidemia should that be confirmed (see <bold>Step 3</bold>).</p>
          <p>In addition to elevated methylmalonic acid, the following biochemical findings may also be seen:</p>
          <list list-type="bullet">
            <list-item>
              <p>Presence of 3-hydroxypropionate, 2-methylcitrate, and tiglylglycine detected on GC/MS analysis of urine</p>
            </list-item>
            <list-item>
              <p>Elevated plasma concentration of glycine on plasma amino acid analysis</p>
            </list-item>
            <list-item>
              <p>Elevated plasma concentration of propionylcarnitine (C3) and variable elevations in C4-dicarboxylic or methylmalonic/succinylcarnitine (C4DC) measured by TMS</p>
            </list-item>
          </list>
          <p><bold>Step 3.</bold> Once elevation of methylmalonic acidemia and aciduria have been established, a normal plasma homocysteine and vitamin B<sub>12</sub> level can help differentiate isolated MMA from other disorders (see <xref ref-type="fig" rid="mma.F2">Figure 2</xref>, left two columns). Note: Although plasma and/or urine methylmalonic acid concentration can be precisely quantitated (<xref ref-type="table" rid="mma.T.methylmalonic_acid_concentration_i">Table 1</xref>), this is generally not needed immediately for diagnostic purposes.</p>
          <table-wrap id="mma.T.methylmalonic_acid_concentration_i" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Methylmalonic Acid Concentration in Phenotypes and Enzymatic Subtypes of Methylmalonic Acidemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1">Methylmalonic Acidemia Phenotype/Enzymatic Subtype&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Methylmalonic Acid Concentration</th>
                </tr>
                <tr>
                  <th headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2" id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Urine&#x000a0;<sup>2</sup></th>
                  <th headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2" id="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Blood</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Infantile/non-B<sub>12</sub>-responsive&#x000a0;<sup>3</sup>
<break/><italic toggle="yes">mut</italic><sup>0</sup>, <italic toggle="yes">mut<sup>&#x02013;</sup></italic>, <italic toggle="yes">cblB</italic></td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1000-10,000 mmol/mol Cr</td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">100-1000 &#x000b5;M</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">B<sub>12</sub>-responsive&#x000a0;<sup>3</sup>
<italic toggle="yes">cblA</italic>, <italic toggle="yes">cblD</italic>-MMA<break/><italic toggle="yes">cblB</italic>, <italic toggle="yes">mut</italic><sup>&#x02013;</sup> (rare)</td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Tens - hundreds mmol/mol Cr</td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">5-100 &#x000b5;M</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">"Benign"/adult methylmalonic acidemia&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">10-100 mmol/mol Cr</td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">100 &#x000b5;M</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">MCEE deficiency&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">50-1,500 mmol/mol Cr</td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">7 &#x000b5;M</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Normal&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;4 mmol/mol Cr&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_1_2 hd_h_mma.T.methylmalonic_acid_concentration_i_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;0.27 &#x000b5;M&#x000a0;<sup>7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>ND = not determined</p>
              </fn>
              <fn>
                <p>MCEE: methylmalonyl-CoA epimerase</p>
              </fn>
              <fn id="mma.TF.1.1">
                <label>1.&#x000a0;</label>
                <p>Biochemical parameters and clinical phenotype are not always concordant, partly because renal function can influence plasma MMA concentration [<xref ref-type="bibr" rid="mma.REF.kruszka.2013.990">Kruszka et al 2013</xref>, <xref ref-type="bibr" rid="mma.REF.manoli.2013.13552">Manoli et al 2013</xref>]. Patients in kidney failure show massive elevations in plasma MMA that can exceed 5,000 &#x000b5;M.</p>
              </fn>
              <fn id="mma.TF.1.2">
                <label>2.&#x000a0;</label>
                <p>In some centers, analysis of urine by <sup>1</sup>H-NMR spectroscopy can also be used to demonstrate increased methylmalonate concentration [<xref ref-type="bibr" rid="mma.REF.iles.1986.173">Iles et al 1986</xref>].</p>
              </fn>
              <fn id="mma.TF.1.3">
                <label>3.&#x000a0;</label>
                <p>Approximate numbers, representing the author's experience with &#x0003e;80 individuals with the B<sub>12</sub>-responsive and non-B<sub>12</sub>-responsive types</p>
              </fn>
              <fn id="mma.TF.1.4">
                <label>4.&#x000a0;</label>
                <p>From <xref ref-type="bibr" rid="mma.REF.giorgio.1976.310">Giorgio et al [1976]</xref> and converted into &#x000b5;M for plasma concentration</p>
              </fn>
              <fn id="mma.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="mma.REF.bikker.2006.640">Bikker et al [2006]</xref>, <xref ref-type="bibr" rid="mma.REF.dobson.2006.327">Dobson et al [2006]</xref>, <xref ref-type="bibr" rid="mma.REF.nagarajan.2005.517">Nagarajan et al [2005]</xref>, <xref ref-type="bibr" rid="mma.REF.gradinger.2007.1045">Gradinger et al [2007]</xref></p>
              </fn>
              <fn id="mma.TF.1.6">
                <label>6. </label>
                <p>From <xref ref-type="bibr" rid="mma.REF.gradinger.2007.1045">Gradinger et al [2007]</xref></p>
              </fn>
              <fn id="mma.TF.1.7">
                <label>7.&#x000a0;</label>
                <p>Normal values have not been exclusively derived from children or neonates. Some laboratories report urine MMA concentrations in mg/g/Cr (normal: &#x0003c;3 mg/g/Cr) and serum concentrations in nmol/L (normal: &#x0003c;271 nmol/L). The molecular weight of MMA is 118 g/mol.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Step 4.</bold> Vitamin B<sub>12</sub> responsiveness</p>
          <p>In vivo responsiveness to vitamin B<sub>12</sub> should be determined in all affected individuals. No standard regimen has been documented. When stable, affected individuals can be given 1.0 mg of hydroxocobalamin (OH-Cbl) (see Note) intramuscularly or intravenously every day for one to two weeks followed by assessment of production of MMA and related metabolites (3-OH-propionic, 2-methylcitrate) by serial urine organic acid analyses and/or measurement of plasma concentrations of MMA, propionylcarnitine, and homocysteine. A significant (&#x0003e;50%) reduction in metabolite production and plasma concentration(s) is considered to indicate responsiveness [<xref ref-type="bibr" rid="mma.REF.fowler.2008.350">Fowler et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.kruszka.2013.990">Kruszka et al 2013</xref>]. In vivo response was reported in all individuals with <italic toggle="yes">cblA</italic> and only rare individuals with <italic toggle="yes">cblB</italic> [<xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>].</p>
          <p>Note: Hydroxocobalamin (not cyanocobalamin) is the preferred preparation for treatment of methylmalonic acidemia; thus, if the in vivo response to intramuscular hydroxocobalamin is questionable or borderline, vitamin B<sub>12</sub> administration should be continued and a skin biopsy should be obtained to isolate fibroblasts to assess B<sub>12</sub> responsiveness by <sup>14</sup>C propionate incorporation in vitro.</p>
          <p><bold>Step 5.</bold> Molecular genetic testing (<xref ref-type="table" rid="mma.T.summary_of_molecular_genetic_testi">Table 2</xref>) can be used to establish the diagnosis of isolated MMA by identifying biallelic pathogenic variants in one of the five genes (<italic toggle="yes">MUT, MMAA</italic>, <italic toggle="yes">MMAB</italic>, <italic toggle="yes">MCEE,</italic> and <italic toggle="yes">MMADHC)</italic> and confirming carrier status in the parents. In addition, the enzymatic subtype of isolated methylmalonic acidemia is mostly determined by molecular genetic testing due to the limited access to, cost of, and invasive nature of cellular biochemical testing.</p>
          <p>Molecular testing approaches can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Tiered single-gene testing.</bold> Because the phenotype of isolated methylmalonic acidemia can be identical regardless of the mutated gene, molecular genetic testing can be performed in the following order:</p>
              <list list-type="order">
                <list-item>
                  <label>1</label>
                  <p><italic toggle="yes">UT</italic> and <italic toggle="yes">MMAB</italic> in vitamin B<sub>12</sub>-non-responsive individuals</p>
                </list-item>
                <list-item>
                  <label>2</label>
                  <p><italic toggle="yes">MMAA</italic> in vitamin B<sub>12</sub>-responsive individuals</p>
                </list-item>
                <list-item>
                  <label>3</label>
                  <p><italic toggle="yes">MCEE</italic> and <italic toggle="yes">MMADHC</italic> testing if results of testing of the first three genes (<italic toggle="yes">MUT,</italic>
<italic toggle="yes">MMAB,</italic> and <italic toggle="yes">MMAA)</italic> are unrevealing</p>
                  <p>Note: For all genes, sequence analysis is performed first, followed by deletion/duplication analysis if only one pathogenic variant has been detected.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Use of a multi-gene panel</bold> that includes these five genes and other genes in the metabolic pathway (see <xref ref-type="sec" rid="mma.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="mma.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Isolated Methylmalonic Acidemia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2">Proportion of Isolated MMA Attributed to Mutation of This Gene&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Variants Detected by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Deletion / duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MUT</italic>
                  </td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">60%<break/>(78% <italic toggle="yes">mut</italic><sup>0</sup> enzymatic subtype, 22% <italic toggle="yes">mut</italic><sup>&#x02013;</sup> enzymatic subtype)</td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">96%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MMAA</italic>
                  </td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">25%</td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">97%&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MMAB</italic>
                  </td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">12%</td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">98%&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MCEE</italic>
                  </td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">4 probands/families&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
                <tr>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MMADHC</italic>
                  </td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">6 probands/families&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_mma.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown, none reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="mma.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="mma" object-id="mma.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="mma.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="mma.TF.2.2">
                <label>2. </label>
                <p>Based on <xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al [2006]</xref> and <xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al [2007]</xref></p>
              </fn>
              <fn id="mma.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="mma.TF.2.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="mma.TF.2.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al [2006]</xref>
                </p>
              </fn>
              <fn id="mma.TF.2.6">
                <label>6. </label>
                <p>For individuals of Hispanic descent, targeted exon 2 analysis for the <italic toggle="yes">MUT</italic>
<xref ref-type="table" rid="mma.T.mut_pathogenic_missense_variants_d">c.322C&#x0003e;T</xref> pathogenic variant may be considered.</p>
              </fn>
              <fn id="mma.TF.2.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="mma.REF.lernerellis.2004.509">Lerner-Ellis et al [2004]</xref>
                </p>
              </fn>
              <fn id="mma.TF.2.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al [2006]</xref>
                </p>
              </fn>
              <fn id="mma.TF.2.9">
                <label>9. </label>
                <p>
                  <xref ref-type="bibr" rid="mma.REF.gradinger.2007.1045">Gradinger et al [2007]</xref>
                </p>
              </fn>
              <fn id="mma.TF.2.10">
                <label>10. </label>
                <p>
                  <xref ref-type="bibr" rid="mma.REF.stucki.2012.1410">Stucki et al [2012]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Step 6.</bold> Cellular biochemical testing on skin fibroblasts is the gold standard for determining the MMA subtype and B<sub>12</sub> responsiveness in vitro and is useful when the above testing methods fail to provide a firm diagnosis to guide management. For details of biochemical testing, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mma-biochem_testing.pdf" content-type="local-data">here</inline-supplementary-material> (pdf).</p>
          <sec id="mma.Newborn_Screening">
            <title>Newborn Screening</title>
            <p>In the past decade, the implementation of tandem mass spectrometry (MS/MS) in newborn screening (NBS) by many states in the US and countries worldwide has identified newborns with methylmalonic acidemia through detection of elevated concentration of blood propionylcarnitine (C3), a metabolite increased in the blood of individuals with methylmalonic acidemia and the related disorder, propionic acidemia [<xref ref-type="bibr" rid="mma.REF.chace.2001.2040">Chace et al 2001</xref>, <xref ref-type="bibr" rid="mma.REF.therrell.2014.14">Therrell et al 2014</xref>].</p>
            <p>Note: Since propionylcarnitine is one of the analytes most frequently responsible for false positive results, ratios including C3/C2, C3/C0, C3/C16, and new biomarkers such as C16:1OH are recommended in combination with high blood concentration of C3 as decision criteria for &#x0201c;positive&#x0201d; testing in newborn screening acylcarnitine analysis by MS/MS for methylmalonic acidemia and propionic acidemia [<xref ref-type="bibr" rid="mma.REF.lindner.2008.379">Lindner et al 2008</xref>].</p>
            <p>Second-tier testing of 3-hydroxypropionic, methylmalonic, and/or 2-methylcitric acids could be used to reduce the costs and anxiety associated with false positive results [<xref ref-type="bibr" rid="mma.REF.matern.2007.585">Matern et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.la_marca.2008.s395">la Marca et al 2008</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>If C3 and C5OH are increased, the diagnosis of holocarboxylase deficiency and/or <related-object link-type="booklink" source-id="gene" document-id="biotin" document-type="chapter">biotinidase deficiency</related-object> needs to be considered.</p>
              </list-item>
              <list-item>
                <p>Elevated C4-dicarboxylic acylcarnitine (C4DC) is a marker for both methylmalonylcarnitine and succinylcarnitine, and can indicate methylmalonic aciduria associated with succinyl-CoA ligase deficiency [<xref ref-type="bibr" rid="mma.REF.fowler.2008.350">Fowler et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.morava.2009.438">Morava et al 2009</xref>].</p>
              </list-item>
            </list>
            <p>Recommended action (ACT) sheet and confirmatory algorithm describing the basic necessary steps involved in follow up of an infant who has screened positive are available; see American College of Medical Genetics (ACMG) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.acmg.net/StaticContent/ACT/C3-DC.pdf">Newborn Screening ACT Sheet</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinchem.org/content/55/9/1615.long">National Academy of Clinical Biochemistry Guidelines</ext-link> (pdf) [<xref ref-type="bibr" rid="mma.REF.dietzen.2009.1615">Dietzen et al 2009</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="mma.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mma.Clinical_Description">
          <title>Clinical Description</title>
          <p>The phenotypes of isolated methylmalonic acidemia described below that are associated with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype, <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype, <italic toggle="yes">cblA</italic>, <italic toggle="yes">cblB</italic>, and <italic toggle="yes">cblD</italic>-MMA share clinical presentations and a natural history characterized by periods of relative health and intermittent metabolic decompensation, usually associated with intercurrent infections and stress [<xref ref-type="bibr" rid="mma.REF.zwickler.2012.797">Zwickler et al 2012</xref>]. Each such decompensation can be life-threatening. Of note, the natural history of isolated methylmalonic acidemia requires further study, particularly with respect to medical complications including renal disease, the effect of solid organ transplantation, and molecular pathology.</p>
          <p><bold>Infantile/non-B<sub>12</sub>-responsive phenotype (<italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype, <italic toggle="yes">cblB</italic>).</bold> The most common phenotype of isolated methylmalonic acidemia presents during infancy. Infants are normal at birth but rapidly develop lethargy, vomiting, and dehydration on initiation of protein-containing feeds. At presentation, they exhibit hepatomegaly, hypotonia, and in many, hyperammonemic encephalopathy. Laboratory findings typically show a severe, high anion-gap metabolic acidosis, ketosis and ketonuria (highly abnormal in neonates and strongly suggestive of an organic aciduria), hyperammonemia, and hyperglycinemia [<xref ref-type="bibr" rid="mma.REF.matsui.1983.857">Matsui et al 1983</xref>, <xref ref-type="bibr" rid="mma.REF.k_lker.2015a.1041">K&#x000f6;lker et al 2015a</xref>]. Dialysis may be needed especially if hyperammonemia is significant and persistent.</p>
          <p>Thrombocytopenia and neutropenia, suggestive of neonatal sepsis, can be seen.</p>
          <p>The catastrophic neonatal presentation of isolated methylmalonic acidemia can result in death, despite aggressive intervention. Infants with the B<sub>12</sub>-responsive <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype or <italic toggle="yes">cblA</italic> can also present with an acute neonatal crisis.</p>
          <p><bold>Partially deficient or B<sub>12</sub>-responsive phenotypes (<italic toggle="yes">mut</italic></bold><italic toggle="yes"><sup>&#x02013;</sup></italic>
<bold>enzymatic subtype, <italic toggle="yes">cblA</italic>, <italic toggle="yes">cblB</italic> [rare], <italic toggle="yes">cblD</italic>-MMA).</bold> This intermediate phenotype of isolated methylmalonic acidemia can occur in the first few months or years of life. Affected infants can exhibit feeding problems (typically anorexia and vomiting), failure to thrive, hypotonia, and developmental delay. Some have protein aversion and/or clinical symptoms of vomiting and lethargy after protein intake.</p>
          <p>Until the diagnosis is established and treatment initiated these infants are at risk for a catastrophic decompensation (like that in neonates) [<xref ref-type="bibr" rid="mma.REF.shapira.1991.80">Shapira et al 1991</xref>, <xref ref-type="bibr" rid="mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</xref>, <xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>].</p>
          <p>During such an episode of metabolic decompensation, the child may die despite intensive intervention if prompt treatment specific for MMA is not instituted and the symptoms are misdiagnosed as, for example, diabetic ketoacidosis [<xref ref-type="bibr" rid="mma.REF.ciani.2000.2119">Ciani et al 2000</xref>].</p>
          <p>Before the onset of newborn screening, infants with the subtypes <italic toggle="yes">cblA</italic> or <italic toggle="yes">mut<sup>&#x02013;</sup></italic> would present with a devastating injury in the basal ganglia (more specifically lacunar infarcts in the globus pallidus) resulting in a debilitating movement disorder [<xref ref-type="bibr" rid="mma.REF.korf.1986.364">Korf et al 1986</xref>, <xref ref-type="bibr" rid="mma.REF.heidenreich.1988.1022">Heidenreich et al 1988</xref>].</p>
          <p>Patients with partial <italic toggle="yes">mut</italic> enzymatic deficiency, <italic toggle="yes">cblA</italic>, or <italic toggle="yes">cblB</italic> can also present with isolated renal tubular acidosis or chronic renal failure [<xref ref-type="bibr" rid="mma.REF.dudley.1998.564">Dudley et al 1998</xref>, <xref ref-type="bibr" rid="mma.REF.coman.2006.270">Coman et al 2006</xref>].</p>
          <p><bold>Methylmalonyl-CoA epimerase deficiency.</bold> Pathogenic variants in <italic toggle="yes">MCEE</italic> are a very rare cause of persistent moderate methylmalonic aciduria. Findings in infants/children with mutation of <italic toggle="yes">MCEE</italic> have ranged from complete absence of symptoms to severe metabolic acidosis with increased MMA and 2-methylcitrate and ketones in the urine at initial presentation [<xref ref-type="bibr" rid="mma.REF.dobson.2006.327">Dobson et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.gradinger.2007.1045">Gradinger et al 2007</xref>]. Symptoms include ataxia, dysarthria, hypotonia, mild spastic paraparesis, and seizures; however, many affected persons were from consanguineous unions &#x02014; including the first identified individual, who also had a DOPA-responsive dystonia resulting from homozygous pathogenic variants of <italic toggle="yes">SPR</italic>, the gene encoding sepiapterin reductase [<xref ref-type="bibr" rid="mma.REF.bikker.2006.640">Bikker et al 2006</xref>].</p>
          <p><bold>Secondary complications.</bold> Despite increased knowledge about isolated methylmalonic acidemia and possibly earlier symptomatic diagnosis, isolated methylmalonic acidemia continues to be associated with substantial morbidity and mortality [<xref ref-type="bibr" rid="mma.REF.de_baulny.2005.415">de Baulny et al 2005</xref>, <xref ref-type="bibr" rid="mma.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.k_lker.2015b.1059">K&#x000f6;lker et al 2015b</xref>] that correlates with the underlying defect [<xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>]. Individuals with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype and the <italic toggle="yes">cblB</italic> subtype have a higher rate of mortality and neurologic complications than those with the <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype and <italic toggle="yes">cblA</italic>.</p>
          <p>The major secondary complications include:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Intellectual disability.</bold> Intellectual disability may or may not be present even in those with severe disease. In a retrospective, survey-based review, about 50% of individuals with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype and 25% of those with the <italic toggle="yes">cblA</italic>/<italic toggle="yes">cblB</italic> enzymatic subtype had an IQ below 80 and significant neurologic impairment [<xref ref-type="bibr" rid="mma.REF.baumgarter.1995.138">Baumgarter &#x00026; Viardot 1995</xref>].</p>
              <p>In another study about 50% of individuals with <italic toggle="yes">mut<sup>0</sup></italic>, 85% with <italic toggle="yes">mut</italic><sup>&#x02013;</sup>, 48% with <italic toggle="yes">cblA</italic>, and 70% with <italic toggle="yes">cblB</italic> had an IQ above 90 [<xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>].</p>
              <p>In a recent natural history study, the mean FSIQ of all individuals with isolated methylmalonic acidemia (n = 37) was 85.0 &#x000b1; 20.68, which is in the low average range (80 &#x02264; IQ &#x02264;89). Individuals with <italic toggle="yes">cblA</italic> (n = 7), <italic toggle="yes">cblB</italic> (n = 6), and <italic toggle="yes">mut</italic> diagnosed prenatally or by newborn screening (n = 3) had mean FSIQs in the average range (90 &#x02264; IQ &#x02264;109). The age of disease onset, the presence of severe hyperammonemia at diagnosis, and a history of seizures were associated with more severe impairments [<xref ref-type="bibr" rid="mma.REF.oshea.2012.e1541">O'Shea et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Tubulointerstitial nephritis with progressive impairment of renal function.</bold> All individuals with isolated methylmalonic acidemia, even those who are mildly affected or who have received a liver allograft [<xref ref-type="bibr" rid="mma.REF.nyhan.2002.377">Nyhan et al 2002</xref>], are at risk of developing renal insufficiency [<xref ref-type="bibr" rid="mma.REF.walter.1989.344">Walter et al 1989</xref>, <xref ref-type="bibr" rid="mma.REF.kruszka.2013.990">Kruszka et al 2013</xref>]. End-stage renal disease (ESRD) was common in individuals with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype (61%) and the <italic toggle="yes">cblB</italic> (66%) enzymatic subtype, and occurred less frequently in those with the <italic toggle="yes">cblA</italic> (21%) enzymatic subtype [<xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>].</p>
              <p>Secondary mitochondrial dysfunction rather than direct nephrotoxicity of methylmalonic acid is hypothesized. Cell-specific mitochondrial pathology primarily in the proximal tubules, associated with cytochrome <italic toggle="yes">c</italic> oxidase deficiency and increased markers of oxidative stress in the urine and plasma, have been shown in human and mouse studies [<xref ref-type="bibr" rid="mma.REF.atkuri.2009.3941">Atkuri et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.mc_guire.2009.173">Mc Guire et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.manoli.2013.13552">Manoli et al 2013</xref>, <xref ref-type="bibr" rid="mma.REF.zsengell_r.2014.2139">Zsengell&#x000e9;r et al 2014</xref>].</p>
              <p>An acute renal syndrome, seen in the setting of metabolic decompensation, may also exist [<xref ref-type="bibr" rid="mma.REF.stokke.1967.313">Stokke et al 1967</xref>] and requires further clinical delineation. Moreover, renal tubular dysfunction presenting as a decrease in urine concentrating ability and acidification, hyporeninemic hypoaldosteronism, tubular acidosis type 4, and hyperkalemia have been reported in a number of affected individuals, and are supported by murine studies [<xref ref-type="bibr" rid="mma.REF.walter.1989.344">Walter et al 1989</xref>, <xref ref-type="bibr" rid="mma.REF.dangio.1991.259">D'Angio et al 1991</xref>, <xref ref-type="bibr" rid="mma.REF.pela.2006.63">Pela et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.manoli.2013.13552">Manoli et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Neurologic findings.</bold> Some individuals develop a &#x0201c;metabolic stroke&#x0201d; or infarction of the basal ganglia (characteristically the globus pallidus externa) during acute metabolic decompensation, which can produce an incapacitating movement disorder [<xref ref-type="bibr" rid="mma.REF.korf.1986.364">Korf et al 1986</xref>, <xref ref-type="bibr" rid="mma.REF.heidenreich.1988.1022">Heidenreich et al 1988</xref>]. The reported incidence in different cohorts is 17%-30% [<xref ref-type="bibr" rid="mma.REF.baumgarter.1995.138">Baumgarter &#x00026; Viardot 1995</xref>, <xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>]. Distinct segments of the globus pallidus (and sometimes the substrantia nigra in the cerebral peduncles) are affected, suggesting a non-uniform, cell-specific sensitivity to the mechanism of infarct [<xref ref-type="bibr" rid="mma.REF.baker.2015.194">Baker et al 2015</xref>].</p>
              <p>Delayed myelination, incomplete opercularization, subcortical white matter changes, and brain stem and cerebellar changes have been described [<xref ref-type="bibr" rid="mma.REF.harting.2008.368">Harting et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.radmanesh.2008.1054">Radmanesh et al 2008</xref>].</p>
              <p>Of note, individuals who have undergone liver and/or kidney transplantation can develop acute lesions without overt metabolic decompensation, suggesting that the enzyme deficiency in the brain remains unchanged and trapping of toxic metabolites in the CNS compartment can lead to injury despite other systemic benefits of the transplantation [<xref ref-type="bibr" rid="mma.REF.chakrapani.2002.261">Chakrapani et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.kaplan.2006.322">Kaplan et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.vernon.2014.899">Vernon et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Pancreatitis.</bold> The incidence of pancreatitis in isolated methylmalonic acidemia is unknown, but it is a well-recognized complication [<xref ref-type="bibr" rid="mma.REF.kahler.1994.239">Kahler et al 1994</xref>]. It can occur acutely or chronically. Pancreatitis may be under-recognized because it can manifest nonspecifically with vomiting and abdominal pain.</p>
            </list-item>
            <list-item>
              <p><bold>Growth failure.</bold> Growth failure is frequent and multifactorial. It is the result of severe chronic illness and perhaps relative protein malnutrition that is complicated further by chronic renal failure. Many infants are less than three standard deviations below normal for both length and weight.</p>
              <p>Some children have documented growth hormone (GH) deficiency, but response to GH therapy may vary (see <xref ref-type="sec" rid="mma.Management">Management</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Functional immune impairment.</bold> This results in an increased susceptibility to severe infections, particularly by fungal and gram-negative organisms [<xref ref-type="bibr" rid="mma.REF.oberholzer.1967.492">Oberholzer et al 1967</xref>, <xref ref-type="bibr" rid="mma.REF.wong.1992.180">Wong et al 1992</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Bone marrow failure.</bold> During episodes of metabolic decompensation patients can exhibit pancytopenia, with bone marrow hypoplasia and/or dysplasia that most frequently revert to normal with supportive care.</p>
            </list-item>
            <list-item>
              <p><bold>Optic nerve atrophy.</bold> Late-onset optic atrophy associated with acute visual loss, resembling the presentation of the mitochondrial disorder <related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">Leber hereditary optic neuropathy</related-object> (LHON), has been reported in isolated methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.wasserstein.1999.788">Wasserstein et al 1999</xref>, <xref ref-type="bibr" rid="mma.REF.williams.2009.929">Williams et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.pinarsueiro.2010.s199">Pinar-Sueiro et al 2010</xref>, <xref ref-type="bibr" rid="mma.REF.traber.2011.344">Traber et al 2011</xref>], as well as in propionic acidemia [<xref ref-type="bibr" rid="mma.REF.williams.2009.929">Williams et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.martinez_alvarez.2016.98">Martinez Alvarez et al 2016</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Hepatoblastoma</bold>. Isolated instances of hepatoblastoma have been reported in the native or donor liver in individuals with <italic toggle="yes">mut</italic> MMA; however, the overall incidence of cancer in these patients is unknown [<xref ref-type="bibr" rid="mma.REF.cosson.2008.107">Cosson et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.chan.2015.635">Chan et al 2015</xref>]</p>
            </list-item>
          </list>
          <p><bold>Survival</bold> in isolated methylmalonic acidemia has improved over time [<xref ref-type="bibr" rid="mma.REF.matsui.1983.857">Matsui et al 1983</xref>, <xref ref-type="bibr" rid="mma.REF.van_der_meer.1994.903">van der Meer et al 1994</xref>, <xref ref-type="bibr" rid="mma.REF.baumgarter.1995.138">Baumgarter &#x00026; Viardot 1995</xref>, <xref ref-type="bibr" rid="mma.REF.nicolaides.1998.508">Nicolaides et al 1998</xref>, <xref ref-type="bibr" rid="mma.REF.k_lker.2015a.1041">K&#x000f6;lker et al 2015a</xref>].</p>
          <p>In those with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype, survival at age one year has improved from 65% in the 1970s to more than 90% in the 1990s; five-year survival has improved from 33% in the 1970s to more than 80% in the 1990s.</p>
          <p>In one series, the median age of death of those with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype was compared over time: 100% died at a median age of 1.6 years in the 1970s, 50% died at a median age of 7.6 years in the 1980s, and 20% died at a median age of 2.2 years in the 1990s. Overall mortality was about 50% for those with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype (median age of death 2 years) as compared to 50% for the <italic toggle="yes">cblB</italic> enzymatic subtype (median age of death 2.9 years), 40% for the <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype, (median age of death 4.5 years) and about 5% for the <italic toggle="yes">cblA</italic> enzymatic subtype (1 death at 14 days) [<xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>].</p>
          <p>The effect of early organ transplantation on overall survival has not been systematically studied.</p>
          <p><bold>Effect of newborn screening.</bold> The limited number of infants detected by newborn screening (NBS) and the short duration of their follow up do not allow conclusions regarding the effect of NBS on the long-term outcome of methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.leonard.2003.s21">Leonard et al 2003</xref>, <xref ref-type="bibr" rid="mma.REF.dionisivici.2006.383">Dionisi-Vici et al 2006</xref>]. Moreover, it must be emphasized that a significant number of infants with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype may present clinically before the NBS results become available. Limited observations in sibs with the <italic toggle="yes">cblA</italic> enzymatic subtype suggest that the IQs of the individuals treated from the newborn period were significantly better than those of their older affected sibs who were diagnosed after the onset of symptoms [<xref ref-type="bibr" rid="mma.REF.h_rster.2007.225">H&#x000f6;rster et al 2007</xref>].</p>
          <p>Of note, before the availability of newborn screening individuals with <italic toggle="yes">cblA</italic> and some with <italic toggle="yes">cblB</italic> often manifested in early childhood with encephalopathy and globus pallidus injury, which in theory could have been avoided if they had been detected by NBS and treated before symptoms appeared.</p>
        </sec>
        <sec id="mma.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Precise genotype-phenotype correlations are difficult to determine since most affected individuals are compound heterozygotes.</p>
          <p>Homozygosity for the <xref ref-type="table" rid="mma.T.mut_pathogenic_missense_variants_d">p.Asn219Tyr</xref>
<italic toggle="yes">MUT</italic> pathogenic variant is frequently associated with severe mutase deficiency (i.e., the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype) [<xref ref-type="bibr" rid="mma.REF.acquaviva.2001.577">Acquaviva et al 2001</xref>]. <xref ref-type="table" rid="mma.T.mut_pathogenic_missense_variants_d">p.Arg108Cys</xref>, which is also associated with a <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype, is more common in individuals of Hispanic descent [<xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>].</p>
          <p>Homozygosity for the <xref ref-type="table" rid="mma.T.mut_pathogenic_missense_variants_d">p.Gly717Val</xref>
<italic toggle="yes">MUT</italic> pathogenic variant, which is associated with the <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype [<xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>], is more common in individuals of African descent.</p>
          <p>The clinical phenotype depends on a number of factors that cannot be accurately predicted by the genotype, including whole-body enzyme activity, in vivo responsiveness to cobalamin, environmental factors, and perhaps the efficiency and activation of alternative propionyl-CoA disposal pathways. It is possible that better understanding of clinical correlations in isolated methylmalonic acidemia could be achieved by estimating the amount of whole-body residual metabolic capacity based on stable isotope studies [<xref ref-type="bibr" rid="mma.REF.leonard.1997.s67">Leonard 1997</xref>].</p>
        </sec>
        <sec id="mma.Prevalence">
          <title>Prevalence</title>
          <p>Several studies have estimated the birth prevalence of isolated methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.sniderman.1999.675">Sniderman et al 1999</xref>]. Urine screening for isolated methylmalonic acidemia in Quebec identified "symptomatic methylmalonic aciduria" in approximately 1:80,000 newborns screened [<xref ref-type="bibr" rid="mma.REF.sniderman.1999.675">Sniderman et al 1999</xref>], which approximates the observation of <xref ref-type="bibr" rid="mma.REF.chace.2001.2040">Chace et al [2001]</xref> of ten cases of isolated methylmalonic acidemia identified in a sample of 908,543 newborns screened by mass spectrometry in the US.</p>
          <p>In Japan, the birth prevalence may be as high as 1:50,000 [<xref ref-type="bibr" rid="mma.REF.shigematsu.2002.39">Shigematsu et al 2002</xref>].</p>
          <p>It appears that the prevalence of isolated methylmalonic acidemia may therefore fall between 1:50,000 and 1:100,000; confirmation, however, would require larger studies.</p>
        </sec>
      </sec>
      <sec id="mma.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with biallelic pathogenic variants in <italic toggle="yes">MUT,</italic>
<italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB</italic>, or <italic toggle="yes">MCEE.</italic></p>
        <p>One individual with <italic toggle="yes">mut<sup>0</sup></italic> MMA and insulin-dependent diabetes mellitus caused by paternal isodisomy of chromosome 6 has been reported [<xref ref-type="bibr" rid="mma.REF.abramowicz.1994.418">Abramowicz et al 1994</xref>].</p>
        <p><italic toggle="yes">MMADHC</italic> biallelic pathogenic variants are also associated with <italic toggle="yes">cblD</italic>-combined (methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria) and <italic toggle="yes">cblD</italic>-homocystinuria (hyperhomocysteinemia/homocystinuria), which are discussed in <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">Disorders of Intracellular Cobalamin Metabolism</related-object>.</p>
      </sec>
      <sec id="mma.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Atypical methylmalonic acidemia</bold> is associated with increased, usually mild urinary excretion of methylmalonate. Rare defects, such as succinate-CoA ligase deficiency, combined malonic and methylmalonic aciduria, <italic toggle="yes">cblX</italic> deficiency, transcobalamin receptor defect, and methylmalonate semialdehyde dehydrogenase deficiency can cause methylmalonic acidemia/aciduria, although most patients will have additional biochemical findings.</p>
        <p>The only known X-linked disorder related to the intracellular cobalamin metabolic pathway is <italic toggle="yes">cblX</italic> deficiency, caused by mutation of <italic toggle="yes">HCFC1</italic> and associated with combined methylmalonic acidemia and hyperhomocysteinemia, severe intellectual disability, complex seizures, and other neurologic findings. <italic toggle="yes">cblX</italic> deficiency is a recently described disorder with unknown spectrum, but likely to include X-linked developmental delay either without biochemical abnormalities or with isolated elevations of methylmalonic acid.</p>
        <p><bold>"Benign" methylmalonic acidemia.</bold> Newborn screening in the province of Quebec identified infants with mild-to-moderate urinary methylmalonic acid excretion. Follow up revealed resolution in more than 50% of children, as well as an apparently benign, persistent, low-moderate methylmalonic acidemia in some [<xref ref-type="bibr" rid="mma.REF.ledley.1984.1015">Ledley et al 1984</xref>, <xref ref-type="bibr" rid="mma.REF.sniderman.1999.675">Sniderman et al 1999</xref>]. Additional individuals with a relatively benign type of methylmalonic acidemia have been reported [<xref ref-type="bibr" rid="mma.REF.coulombe.1981.26">Coulombe et al 1981</xref>, <xref ref-type="bibr" rid="mma.REF.martens.2002.219">Martens et al 2002</xref>]. Caution is necessary in follow up of these individuals as some can belong to a mild <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype and carry a significant risk for acute metabolic crisis [<xref ref-type="bibr" rid="mma.REF.shapira.1991.80">Shapira et al 1991</xref>].</p>
        <p>The long-term outcome and clinical phenotype of these individuals awaits further description. Of note, a subgroup had a combined biochemical phenotype of malonic and methylmalonic acidemia and, therefore likely represents combined malonic and methylmalonic (CMAMMA) caused by ACSF3 deficiency.</p>
        <p><bold>Combined malonic and methylmalonic aciduria (CMAMMA) caused by ACSF3 deficiency.</bold> Patients with CMAMMA show high malonic acid (MA) and methylmalonic acid (MMA) levels in their urine or plasma, with MMA excretion typically being higher than MA excretion (MMA/MA &#x0003e;5). Because C3 (propionylcarnitine) is not elevated, infants with CMAMMA are not detected by newborn screening based on a dried blood spot acylcarnitine analysis.</p>
        <p>The phenotypic spectrum is broad, ranging from completely asymptomatic individuals to adults with neurologic syndromes (seizures, memory problems, psychiatric disease, and/or cognitive decline) or children with a wide range of manifestations, such as coma, ketoacidosis, hypoglycemia, failure to thrive, elevated transaminases, microcephaly, dystonia, axial hypotonia, and/or developmental delay. The full natural history of this disorder remains to be elucidated.</p>
        <p>Mutation of <italic toggle="yes">ACSF3</italic> (encoding a methylmalonyl- and malonyl-CoA synthetase that produces the first substrate, malonyl-CoA, for intra-mitochondrial fatty acid synthesis) is causative [<xref ref-type="bibr" rid="mma.REF.alfares.2011.602">Alfares et al 2011</xref>, <xref ref-type="bibr" rid="mma.REF.sloan.2011.883">Sloan et al 2011</xref>].</p>
        <p><bold>Methylmalonate semialdehyde dehydrogenase deficiency (MMSDH).</bold> In the last enzymatic steps in the valine degradation pathway, 3-hydroxyisobutyrate dehydrogenase converts 3-hydroxyisobutyrate to (S)-methylmalonic semialdehyde (MMSA), and methylmalonate semialdehyde dehydrogenase (MMSDH) converts (S)-methylmalonic semialdehyde to propionyl-CoA). Of note, the same enzyme catalyzes the oxidative decarboxylation of the (R)-methylmalonic semialdehyde enantiomer generated from thymine metabolism to propionyl-CoA.</p>
        <p>A small number of patients with pathogenic variants in <italic toggle="yes">ALDH6A1,</italic> which encodes the MMSDH enzyme, have had extremely variable biochemical phenotypes: some have displayed 3-hydroxyisobutyric aciduria [<xref ref-type="bibr" rid="mma.REF.chambliss.2000.497">Chambliss et al 2000</xref>, <xref ref-type="bibr" rid="mma.REF.sass.2012.437">Sass et al 2012</xref>], while others have also displayed transient methylmalonic acidemia/aciduria [<xref ref-type="bibr" rid="mma.REF.marcadier.2013.98">Marcadier et al 2013</xref>]. They have also had extremely variable clinical phenotypes, including severe intellectual impairment associated with significant brain myelination defects.</p>
        <p><bold>Transcobalamin receptor defect (TCblR/CD320).</bold> The index case and four additional affected individuals were asymptomatic newborns identified on NBS with an elevated C3 and elevated C3/C2 ratio. They also had increased plasma and urine MMA and normal serum vitamin B<sub>12</sub> levels; two of the four were stated to have elevated homocysteine.</p>
        <p>In the index case, biochemical abnormalities normalized with a single hydroxocobalamin injection and remained normal for nine months [<xref ref-type="bibr" rid="mma.REF.quadros.2010.3033">Quadros et al 2010</xref>]. Fibroblasts showed decreased uptake of transcobalamin.</p>
        <p>A <italic toggle="yes">CD320</italic> pathogenic variant was also identified in a boy age seven weeks with retinal artery occlusions born to consanguineous parents [<xref ref-type="bibr" rid="mma.REF.karth.2012.398">Karth et al 2012</xref>]. All reported affected individuals are homozygous for NM_016579.3:c.262_264del (p.Glu88del). Polymorphisms in the TCblR have been associated with increased risk for neural tube defects in an Irish cohort [<xref ref-type="bibr" rid="mma.REF.pangilinan.2010.677">Pangilinan et al 2010</xref>].</p>
        <p><bold>Combined methylmalonic acidemia and</bold>
<related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter"><bold>hyperhomocysteinemia/homocystinuria</bold></related-object><bold>.</bold> Disorders that interfere with the intracellular metabolism of cobalamin can cause a perturbation in the synthesis of adenosylcobalamin and/or methylcobalamin. However, these conditions are usually accompanied by clinically significant hyperhomocysteinemia. The following are included in this group of disorders:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cobalamin C deficiency (<italic toggle="yes">cblC</italic>) is perhaps the most common inborn error of <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter">intracellular cobalamin metabolism</related-object>. Individuals with this disorder almost always have increased plasma concentrations of homocysteine and methylmalonic acid, with low levels of methionine, and historically a highly variable age of onset. Affected individuals frequently have developmental delay and develop a pigmentary retinopathy and a &#x0201c;bull's eye&#x0201d; maculopathy. <italic toggle="yes">cblC</italic> is caused by biallelic pathogenic variants in <italic toggle="yes">MMACHC</italic> which encodes a protein involved in the processing and trafficking of intracellular cobalamin. The pathogenic variant c.271dupA;p.Arg91LysfsTer14 accounts for approximately 40% of alleles [<xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p>Deficiencies of complementation groups <italic toggle="yes">cblD, cblF,</italic> and <italic toggle="yes">cblJ</italic> are extremely rare autosomal recessive disorders.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold><italic toggle="yes">cblD</italic> deficiency</bold> is biochemically heterogeneous [<xref ref-type="bibr" rid="mma.REF.suormala.2004.42742">Suormala et al 2004</xref>]. <xref ref-type="bibr" rid="mma.REF.coelho.2008.1454">Coelho et al [2008]</xref> determined that mutation of <italic toggle="yes">MMADHC</italic> (previously known as <italic toggle="yes">C2ORF25)</italic> is responsible for <italic toggle="yes">cblD</italic> and identified genotype/phenotype correlations. <italic toggle="yes">MMADHC</italic> has multiple translation initiation codons (ATG), and encodes distant polypeptides. The location and nature of the pathogenic variant therefore determines whether a patient will display methylmalonic aciduria, homocystinuria, or both metabolic abnormalities:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>The <italic toggle="yes">cblD-</italic>methylmalonic aciduria subtype (<italic toggle="yes">cblD</italic>-MMA) (previously known as <italic toggle="yes">cblD-</italic>variant 2) is caused by pathogenic nonsense and frame-shifting variants in exons 3 and 4;</p>
                  </list-item>
                  <list-item>
                    <p>The <italic toggle="yes">cblD-</italic>homocystinuria subtype (previously known as <italic toggle="yes">cblD</italic> variant 1) is caused by pathogenic missense variants in exons 6-8;</p>
                  </list-item>
                  <list-item>
                    <p>A <italic toggle="yes">cblD-</italic>combined subtype (<italic toggle="yes">cblD</italic>) that features elevations of both MMA and homocysteine is caused by frame-shifting pathogenic variants in exon 5, exon 8, and intron 7.</p>
                  </list-item>
                </list>
                <p>Note: Individuals with complementation <italic toggle="yes">cblD</italic>-homocystinuria [<xref ref-type="bibr" rid="mma.REF.coelho.2008.1454">Coelho et al 2008</xref>], <italic toggle="yes">cblE</italic> (methionine synthase reductase), and <italic toggle="yes">cblG</italic> (methionine synthase) abnormalities do not have methylmalonic acidemia, but rather isolated homocystinuria/hyperhomocysteinemia caused by impaired methyl-cobalamin synthesis.</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">cblF</italic> deficiency</bold> is caused by mutation of <italic toggle="yes">LMBRD1</italic>, which encodes a putative lysosomal cobalamin exporter [<xref ref-type="bibr" rid="mma.REF.rutsch.2009.234">Rutsch et al 2009</xref>], affecting the synthesis of the cofactors for the enzyme methylmalonyl-CoA mutase (encoded by <italic toggle="yes">MUT</italic>) and the enzyme methyltetrahydrofolate: homocysteine methyltransferase, also known as methionine synthase (MS) (encoded by <italic toggle="yes">MTR</italic>).</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">cblJ</italic> deficiency</bold> caused by mutation of <italic toggle="yes">ABCD4,</italic> an ATP-binding cassette (ABC) transporter that affects the lysosomal release of Cbl into the cytoplasm similar to cblF and presents with hypotonia, lethargy, poor feeding, bone marrow suppression, macrocytic anemia, and congenital heart disease in some patients [<xref ref-type="bibr" rid="mma.REF.coelho.2012.1152">Coelho et al 2012</xref>].</p>
                <p>It is important to note that several individuals with <italic toggle="yes">cblF or cblJ</italic> can have decreased serum vitamin B<sub>12</sub> levels, suggesting a role for the lysosome in intestinal uptake of ingested cobalamin.</p>
              </list-item>
              <list-item>
                <p><bold><italic toggle="yes">cblX</italic> deficiency</bold> is caused by mutation of the X-linked gene <italic toggle="yes">HCFC1</italic>, a transcriptional co-regulator affecting the expression of <italic toggle="yes">MMACHC</italic>. All described affected males to date had MMAemia and MMAuria, and most, when studied, displayed combined hyperhomocystinuria and methylmalonic acidemia. The clinical phenotype features intractable epilepsy and profound neurocognitive impairment without the specific bulls-eye maculopathy of <italic toggle="yes">cblC</italic> deficiency [<xref ref-type="bibr" rid="mma.REF.yu.2013.506">Yu et al 2013</xref>]; however, the phenotype needs further characterization.</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p><bold>Vitamin B<sub>12</sub> deficiency.</bold> Individuals with vitamin B<sub>12</sub> deficiency can have methylmalonic acidemia and homocystinuria.</p>
        <p>Maternal B<sub>12</sub> deficiency can produce a methylmalonic acidemia syndrome in an infant that ranges from severe encephalopathy to elevated serum concentration of propionylcarnitine (C3) detected by newborn screening [<xref ref-type="bibr" rid="mma.REF.chace.2001.2040">Chace et al 2001</xref>]. This metabolic abnormality can occur in a breast-fed infant of a vegan mother, in an infant born to a mother with subclinical pernicious anemia [<xref ref-type="bibr" rid="mma.REF.marble.2008.731">Marble et al 2008</xref>], and in infants born to mothers who have had gastric surgery [<xref ref-type="bibr" rid="mma.REF.grange.1994.311">Grange &#x00026; Finlay 1994</xref>, <xref ref-type="bibr" rid="mma.REF.celiker.2009.640">Celiker &#x00026; Chawla 2009</xref>]. The mother does not necessarily have a very low serum concentration of vitamin B<sub>12</sub>. intramuscular vitamin B<sub>12</sub> replacement therapy to normalize vitamin B<sub>12</sub> serum concentration reverses the metabolic abnormality.</p>
        <p><bold>Mitochondrial encephalomyopathy with elevated methylmalonic acid.</bold> Mild methylmalonic aciduria has been described in succinate-ligase alpha subunit (caused by biallelic <italic toggle="yes">SUCLG1</italic> pathogenic variants) and succinate-ligase ADP-forming beta subunit (caused by biallelic <italic toggle="yes">SUCLA2</italic> pathogenic variants) associated with mitochondrial DNA depletion presenting with severe lactic acidosis and encephalomyopathy.</p>
        <p>Succinyl-CoA ligase (SUCL) catalyzes the reversible conversion of succinyl-CoA and ADP or GDP to succinate and ATP or GTP, and comprises an &#x003b1; subunit encoded by <italic toggle="yes">SUCLG1</italic> and a &#x003b2; subunit encoded by either <italic toggle="yes">SUCLA2</italic> or <italic toggle="yes">SUCLG2</italic>.</p>
        <p>Biallelic pathogenic variants in <italic toggle="yes">SUCLG1</italic> result in a severe phenotype, associated with lactic acidosis and early death in the first week of life. (See <related-object link-type="booklink" source-id="gene" document-id="suclg1-mtddepl" document-type="chapter"><italic toggle="yes">SUCLG1</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</related-object>.)</p>
        <p>Biallelic <italic toggle="yes">SUCLA2</italic> pathogenic variants are associated with hypotonia, muscle atrophy presenting around ages three to six months (with mtDNA depletion, complex I, III, and IV deficiency in the muscle), hyperkinesia, seizures, severe hearing impairment, and growth failure. Patients develop a Leigh syndrome-like disorder, cortical and basal ganglia atrophy, and dystonia. Some affected individuals die in infancy; others have survived into their 20s. (See <related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-Related mtDNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</related-object>.)</p>
        <p>Methylmalonic aciduria ranges from 10 to 200 mmol/mol creatinine in these individuals and is accompanied by raised plasma concentrations of lactate, methylcitrate, 3-hydroxyproprionic and 3-hydroxyisovaleric acid, proprionylcarnitine, and C4-dicarboxylic carnitine (C4DC) [<xref ref-type="bibr" rid="mma.REF.elpeleg.2005.1081">Elpeleg et al 2005</xref>, <xref ref-type="bibr" rid="mma.REF.carrozzo.2007.862">Carrozzo et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.ostergaard.2007.853">Ostergaard et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.morava.2009.438">Morava et al 2009</xref>].</p>
        <p><bold>Reye-like syndrome.</bold> A Reye-like syndrome of hepatomegaly and obtundation in the face of a mild intercurrent infection can be seen as an unrecognized presentation of a number of inborn errors of metabolism, including isolated methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.chang.2000.295">Chang et al 2000</xref>].</p>
        <p><bold>Other entities</bold> that can display methylmalonic acidemia despite normal methylmalonyl-CoA mutase enzyme activity include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x0201c;Atypical&#x0201d; methylmalonic acidemia with progressive neurodegenerative disease, microcephaly, and cataracts (2 sibs) [<xref ref-type="bibr" rid="mma.REF.str_mme.1995.1">Str&#x000f8;mme et al 1995</xref>] or with a mitochondrial depletion syndrome/complex IV deficiency and combined propionic and methylmalonic acidemia (1 person) [<xref ref-type="bibr" rid="mma.REF.yano.2003.481">Yano et al 2003</xref>]. These cases have similarities with the phenotype caused by mutation of <italic toggle="yes">SUCLA2</italic>.</p>
          </list-item>
          <list-item>
            <p>Benign methylmalonic acidemia with distal renal tubular acidosis (one sibship) [<xref ref-type="bibr" rid="mma.REF.dudley.1998.564">Dudley et al 1998</xref>]</p>
          </list-item>
          <list-item>
            <p>Malonyl-CoA decarboxylase deficiency, usually associated with combined methylmalonic and malonic aciduria, with significantly higher malonic versus methylmalonic acid levels [<xref ref-type="bibr" rid="mma.REF.brown.1984.21">Brown et al 1984</xref>]</p>
          </list-item>
          <list-item>
            <p>Isolated methylmalonic aciduria and normal plasma concentrations of methylmalonic acidemia (2 families) [<xref ref-type="bibr" rid="mma.REF.sewell.1996.203">Sewell et al 1996</xref>, <xref ref-type="bibr" rid="mma.REF.martens.2002.219">Martens et al 2002</xref>]</p>
          </list-item>
        </list>
      </sec>
      <sec id="mma.Management">
        <title>Management</title>
        <sec id="mma.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with isolated methylmalonic acidemia, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>A serum chemistry panel (Na<sup>+</sup>, K<sup>+</sup>, CI<sup>&#x02013;</sup>, glucose, urea, creatinine, bicarbonate, AST, ALT, alkaline phosphatase, bilirubin [T/U], triglycerides, and cholesterol); complete blood count with differential; arterial or venous blood gas; plasma ammonium and lactic acid concentration; formal urinalysis and ketone measurement; quantitative plasma amino acids; and urine organic acid analysis by gas chromatography and mass spectrometry (GC-MS)</p>
            </list-item>
            <list-item>
              <p>If possible, measurement of plasma concentrations of methylmalonic acid, methylcitrate, free and total carnitine, and an acylcarnitine profile to document propionylcarnitine (C3 species) concentration</p>
            </list-item>
            <list-item>
              <p>Measurement of serum vitamin B<sub>12</sub> concentration to determine if a nutritional deficiency is present in the patient and possibly the mother (in newborns)</p>
            </list-item>
            <list-item>
              <p>Biochemical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="mma.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>No consensus exists among various metabolic centers regarding treatment of acute and chronic complications of methylmalonic acidemia. Recent guidelines developed by professionals across 12 European countries and the US based on rigorous literature evaluation and expert group meetings outline the current management recommendations and areas for further research [<xref ref-type="bibr" rid="mma.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>].</p>
          <p>
            <bold>Stabilization of critically ill individuals</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Volume replacement with isotonic solutions</p>
            </list-item>
            <list-item>
              <p>All IV solutions should contain glucose, preferably D<sub>10</sub> or D<sub>12.5</sub>. If hyperglycemia develops, an insulin infusion may be needed.</p>
            </list-item>
            <list-item>
              <p>The total base deficit should be followed serially with repeat electrolyte and venous or arterial blood gas measurements and corrected by hydration and bicarbonate replacement, as needed [<xref ref-type="bibr" rid="mma.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]. Adequate kcals must be delivered. Central or peripheral total parenteral nutrition (TPN), which typically contains glucose and amino acids, and in some instances, lipids, may be required. Total protein administration is usually completely withdrawn for no more than 24-48 hours and reinstated gradually depending on the patient's acid-base balance and remaining test values, including ammonia, lactic acid, and plasma amino acids among others.</p>
            </list-item>
            <list-item>
              <p>Lipid infusions must be used with caution for the risk of pancreatitis.</p>
            </list-item>
            <list-item>
              <p>Carnitine may be administered intravenously at 50-100 mg/kg/d bid-qid.</p>
            </list-item>
            <list-item>
              <p>Urine output and serum sodium and potassium concentration need to be monitored.</p>
            </list-item>
            <list-item>
              <p>Dietary protein should be reintroduced enterally as soon as is feasible given the clinical scenario and may need to be further augmented with TPN. Nasograstric or orogastric feeding should be strongly considered so that enteral feedings can be reintroduced without delay.</p>
            </list-item>
            <list-item>
              <p>N-carbamylglutamate (NCG, Carbaglu<sup>&#x000ae;</sup>) may be considered in the event of hyperammonemia. NCG allosterically activates CPS1 (carbamyl phosphate synthetase 1), the first step of the urea cycle. It has been effective in normalizing the blood ammonia concentration in patients with a deficiency of NAGS (N-acetylglutamate synthase) and can also benefit some patients with propionic and possibly methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.tuchman.2008.213">Tuchman et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.ah_mew.2010.e208">Ah Mew et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Hemodialysis or hemofiltration may be required in the event of treatment failure (uncontrollable acidosis and/or hyperammonemia).</p>
            </list-item>
          </list>
          <p>A letter given to the family to present to emergency department physicians that specifies the recommended acute management protocol should be standard of care.</p>
          <p>Medic Alert<sup>&#x000ae;</sup> bracelets and emergency treatment protocols outlining fluid and electrolyte therapy should be available for all affected individuals.</p>
          <p>
            <bold>Other</bold>
          </p>
          <p>Aside from episodes of critical illness, patients with intercurrent illness such as viral infection or those undergoing surgery for various reasons should have aggressive fluid, metabolic, and nutritional management.</p>
          <p>Specialists in physiatry, physical therapy, and occupational therapy can help address the complex challenges faced by patients and families, maximize functionality, and improve quality of life [<xref ref-type="bibr" rid="mma.REF.ktena.2015b.847">Ktena et al 2015b</xref>].</p>
          <p>Special considerations regarding choices of anesthetic agents in this patient population may apply [<xref ref-type="bibr" rid="mma.REF.ktena.2015a.2075">Ktena et al 2015a</xref>, <xref ref-type="bibr" rid="mma.REF.ruzkova.2015.807">Ruzkova et al 2015</xref>].</p>
          <p>Most individuals require "sick day" management regimens, which typically consist of reducing or eliminating protein intake and increasing fluids and glucose to ensure delivery of adequate calories and to arrest lipolysis. Immediate hospitalization is usually required if signs suggest intercurrent infection.</p>
          <p>Although all of the treatments discussed above may be needed in fragile individuals, they still may not prevent death, the severe sequelae of metabolic decompensation (e.g., metabolic stroke of the basal ganglia), or renal disease. The correlation and identification of treatment patterns and outcomes is needed to develop more effective management protocols for individuals with isolated methylmalonic acidemia.</p>
          <p>Many affected individuals require gastrostomy/gastrojejunostomy tube feeding because of anorexia and vomiting to ensure caloric and fluid intake and improve growth.</p>
          <p>Bone marrow failure during episodes of metabolic decompensation on rare occasion requires granulocyte-colony stimulating factor (GCSF).</p>
          <p>Anemia is an expected complication of chronic renal failure and is treated with erythropoietin and eventually renal transplantation [<xref ref-type="bibr" rid="mma.REF.inoue.1981.95">Inoue et al 1981</xref>, <xref ref-type="bibr" rid="mma.REF.guerramoreno.2003.17">Guerra-Moreno et al 2003</xref>, <xref ref-type="bibr" rid="mma.REF.macfarland.2015.1840">MacFarland &#x00026; Hartung 2015</xref>].</p>
          <p>Some children have had documented growth hormone (GH) deficiency; however, because response to GH therapy may vary, diet and GH replacement dose need to be carefully adjusted [<xref ref-type="bibr" rid="mma.REF.bain.1995.850">Bain et al 1995</xref>, <xref ref-type="bibr" rid="mma.REF.alowain.2004.239">Al-Owain et al 2004</xref>]. The indications for GH replacement therapy and the response to GH replacement in treated individuals require further investigation.</p>
        </sec>
        <sec id="mma.Prevention_of_Primary_Manifestations">
          <title>Prevention of Primary Manifestations</title>
          <sec id="mma.Dietary_Management">
            <title>Dietary Management</title>
            <p><bold>Nutrition.</bold> After stabilization, nutritional management is critical. This typically includes instituting a low-protein, high-calorie diet. When available, accurate assessment of resting energy expenditure can guide dietary and caloric prescriptions and eliminate overfeeding [<xref ref-type="bibr" rid="mma.REF.hauser.2011.47">Hauser et al 2011</xref>].</p>
            <p>Natural protein needs to be carefully titrated to allow for normal growth, while avoiding an excessive propiogenic amino acid load (isoleucine, valine, methionine and threonine) into the pathway. Adjustment of dietary whole (complete)-protein intake, based on clinical and laboratory findings, is needed throughout life for these patients.</p>
            <p>The <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/43411/1/WHO_TRS_935_eng.pdf">FAO/WHO/UNU report</ext-link> [2007] recommended that safe levels per age group should be the aim for natural protein intake [<xref ref-type="bibr" rid="mma.REF.baumgartner.2014.130">Baumgartner et al 2014</xref>]; however, the individual protein amount prescribed will depend on growth parameters, metabolic stability, stage of renal failure, and other factors. A propiogenic amino acid-deficient formula (e.g., Propimex<sup>&#x000ae;</sup>-1/2,<sup>,</sup> XMTVI-1/2, OA-1/2) and protein-free formula (e.g., Pro-Phree<sup>&#x000ae;</sup>, Duocal<sup>&#x000ae;</sup>) are given to some individuals to provide extra fluid and calories. As the infant grows, the total protein load is slowly reduced, based on growth, plasma amino acid concentrations, and plasma and urine methylmalonic acid concentrations.</p>
            <p>Of note, in patients with low protein tolerance, severe restriction of propiogenic amino acid precursors (isoleucine, valine, methionine, and threonine) can produce a nutritional deficiency state. Furthermore, an iatrogenic essential amino acid deficiency can be induced by the relatively high leucine intake through the MMA formulas that can negatively affect long-term growth and possibly other outcomes [<xref ref-type="bibr" rid="mma.REF.manoli.2016b.386">Manoli et al 2016b</xref>]. Medical foods should be used in moderation with the relative intake of natural protein to propiogenic amino-acid deficient formula not exceeding a ratio of 1:1. Isolated valine or isoleucine supplementation should be avoided.</p>
            <p>These dietary guidelines do not apply for patients with <related-object link-type="booklink" source-id="gene" document-id="cbl" document-type="chapter"><italic toggle="yes">CblC</italic> deficiency</related-object>, a separate disorder in the pathway [<xref ref-type="bibr" rid="mma.REF.manoli.2016a.396">Manoli et al 2016a</xref>].</p>
            <p><bold>Hydroxocobalamin injections.</bold> 1.0-mg injections every day to every other day are usually required in individuals who are vitamin B<sub>12</sub> responsive. The regimen of B<sub>12</sub> injections needs to be individually adjusted according to the patient's age and, possibly, weight.</p>
            <p><bold>Carnitine</bold> can be given at a dose of 50-100 mg/kg/day, up to approximately 300 mg/kg/day. As a dietary supplement, carnitine may replace the free carnitine pool and enhance the conjugation and excretion of propionylcarnitine. The contribution of propionylcarnitine excretion to the total propionate load is, however, small. The relief of intracellular CoA accretion may be the mechanism by which carnitine supplementation benefits some individuals.</p>
            <p><bold>Antibiotics.</bold> A variety of antibiotic regimens to reduce the production of propionate from gut flora can be used:</p>
            <list list-type="bullet">
              <list-item>
                <p>Oral neomycin, 250 mg by mouth 4x/day, was the original regimen reported by <xref ref-type="bibr" rid="mma.REF.snyderman.1972.925">Snyderman et al [1972]</xref>.</p>
              </list-item>
              <list-item>
                <p>Metronidazole at 10-15 mg/kg/day has also been reported.</p>
              </list-item>
            </list>
            <p>The intervals at which affected individuals are treated may vary, but a typical course is one week to ten days of treatment per one to three months.</p>
            <p>Although oral antibiotics reduce the propionate load that derives from gut flora in affected individuals, chronic antibiotic therapy is not innocuous; it introduces the risk of repopulation of the individual with resistant flora. This could pose a serious infectious threat and could be especially dangerous to individuals with isolated methylmalonic acidemia, since most deaths are related to metabolic decompensation, often precipitated by infection.</p>
            <p>Response to antibiotic administration should be determined in treated persons by demonstrating either a decrease in whole body output of methylmalonic acid on antibiotic therapy by a timed urine collection or a decrease in the plasma methylmalonic acid concentration compared to the baseline value for that individual.</p>
            <p>Rotating antibiotic regimens may be considered in some persons.</p>
            <p><bold>Antioxidants.</bold> One individual with isolated methylmalonic acidemia who was documented to be glutathione deficient after a severe metabolic crisis responded to ascorbate therapy [<xref ref-type="bibr" rid="mma.REF.treacy.1996.445">Treacy et al 1996</xref>]. Several recent studies document increased oxidative stress, glutathione depletion, and specific respiratory chain complex deficiencies in persons with the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype with methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.schwab.2006.107">Schwab et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.atkuri.2009.3941">Atkuri et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.chandler.2009.1252">Chandler et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.de_keyzer.2009.91">de Keyzer et al 2009</xref>, <xref ref-type="bibr" rid="mma.REF.manoli.2013.13552">Manoli et al 2013</xref>], suggesting a potential benefit of treatment with antioxidants or other mitochondria-targeted therapies in these patients.</p>
            <p>A regimen of coenzyme Q<sub>10</sub> and vitamin E has been shown to prevent progression of acute optic nerve involvement in a patient with MMA [<xref ref-type="bibr" rid="mma.REF.pinarsueiro.2010.s199">Pinar-Sueiro et al 2010</xref>] and was shown to attenuate the progression of kidney disease in a mouse model of MMA [<xref ref-type="bibr" rid="mma.REF.manoli.2013.13552">Manoli et al 2013</xref>].</p>
          </sec>
          <sec id="mma.Organ_Transplantation">
            <title>Organ Transplantation</title>
            <p>The number of individuals who have undergone liver and/or kidney transplantation, the detailed effects on the underlying metabolic disorder, and the overall outcome in those undergoing this procedure have yet to be determined [<xref ref-type="bibr" rid="mma.REF.sloan.2015.1346">Sloan et al 2015</xref>]. Inclusion of enzymatic and genotype information in case series of transplanted patients will allow better comparisons of the outcomes and genotype-phenotype associations that could inform decisions about the indication and timing of transplantation in individual cases.</p>
            <p><bold>Liver transplantation</bold>. Because most of the metabolic conversion of propionate occurs in the liver, replacing the liver could contribute enough enzyme activity to avert metabolic decompensation. Liver transplantation has been shown to largely protect against metabolic instability but is not curative, and individuals with isolated MMA remain at risk for long-term complications of MMA including renal disease, basal ganglia injury, and neurologic complications [<xref ref-type="bibr" rid="mma.REF.chakrapani.2002.261">Chakrapani et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.nyhan.2002.377">Nyhan et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.kaplan.2006.322">Kaplan et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.vernon.2014.899">Vernon et al 2014</xref>]. To date, more than 35 individuals with isolated methylmalonic acidemia have undergone living donor or cadaveric, orthotopic, or partial liver transplantation or combined liver-kidney transplantation (&#x0003e;20 patients) [van't Hoff et al 1998, <xref ref-type="bibr" rid="mma.REF.vant_hoff.1999.s70">van't Hoff, McKiernan et al 1999</xref>, <xref ref-type="bibr" rid="mma.REF.kayler.2002.295">Kayler et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.nyhan.2002.377">Nyhan et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.hsui.2003.171">Hsui et al 2003</xref>, <xref ref-type="bibr" rid="mma.REF.kasahara.2006.943">Kasahara et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.morioka.2007.2782">Morioka et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.mcguire.2011.e142">McGuire et al 2011</xref>, <xref ref-type="bibr" rid="mma.REF.niemi.2015.1455">Niemi et al 2015</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>The underlying biochemical parameters and the frequency of metabolic decompensation improved significantly in individuals undergoing liver transplantation despite persistent metabolic abnormalities [<xref ref-type="bibr" rid="mma.REF.nyhan.2002.377">Nyhan et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.kaplan.2006.322">Kaplan et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.niemi.2015.1455">Niemi et al 2015</xref>], probably as a result of increased extrahepatorenal methylmalonic acid production primarily from the skeletal muscle [<xref ref-type="bibr" rid="mma.REF.chandler.2007.64">Chandler et al 2007</xref>].</p>
              </list-item>
              <list-item>
                <p>Following liver transplantation, some individuals continued to have progressive renal failure as well as high CSF concentrations of methylmalonic acid [<xref ref-type="bibr" rid="mma.REF.nyhan.2002.377">Nyhan et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.kaplan.2006.322">Kaplan et al 2006</xref>].</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Neurologic complications post-transplant, including globus pallidus injuries [<xref ref-type="bibr" rid="mma.REF.chakrapani.2002.261">Chakrapani et al 2002</xref>, <xref ref-type="bibr" rid="mma.REF.cosson.2008.107">Cosson et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.mcguire.2011.e142">McGuire et al 2011</xref>] suggest that adequate protein restriction and supportive care should be continued after the transplantation.</p>
                    <p>Earlier transplantation particularly for individuals with <italic toggle="yes">mut<sup>0</sup></italic> (who are very fragile) is gaining support as surgery techniques and outcomes improve [<xref ref-type="bibr" rid="mma.REF.niemi.2015.1455">Niemi et al 2015</xref>, <xref ref-type="bibr" rid="mma.REF.spada.2015.1173">Spada et al 2015</xref>]. The choice of the kind and timing of the indicated transplant procedure remains challenging for families and treating physicians [<xref ref-type="bibr" rid="mma.REF.sloan.2015.1346">Sloan et al 2015</xref>]. In the long term, the details regarding development of renal disease, optic nerve atrophy, and neurologic complications will be most important.</p>
                  </list-item>
                </list>
              </list-item>
            </list>
            <p><bold>Kidney transplantation</bold>. Some individuals have received only renal allografts [<xref ref-type="bibr" rid="mma.REF.van_calcar.1998.729">Van Calcar et al 1998</xref>, <xref ref-type="bibr" rid="mma.REF.lubrano.2001.848">Lubrano et al 2001</xref>, <xref ref-type="bibr" rid="mma.REF.coman.2006.270">Coman et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.cosson.2008.107">Cosson et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.clothier.2011.695">Clothier et al 2011</xref>].</p>
            <p>One of the first reports on isolated renal transplantation in <italic toggle="yes">mut<sup>0</sup></italic> methylmalonic acidemia was claimed to provide enough enzyme activity to normalize methylmalonic acid excretion and allow for increased dietary protein tolerance; however, it was later determined that that patient had <italic toggle="yes">cblA</italic> deficiency and responded to vitamin B<sub>12</sub>. Thus, this individual, who has a much milder case, is not representative of the outcomes of isolated renal transplantation in individuals with severe MMA subtypes (<italic toggle="yes">mut<sup>0</sup></italic> or <italic toggle="yes">cblB</italic>) [<xref ref-type="bibr" rid="mma.REF.lubrano.2001.848">Lubrano et al 2001</xref>, <xref ref-type="bibr" rid="mma.REF.lubrano.2007.1209">Lubrano et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.lubrano.2013.2067">Lubrano et al 2013</xref>].</p>
            <p>Elective kidney transplantation, even before the onset of renal disease, has been advocated as a form of &#x0201c;cell therapy&#x0201d; to help stabilize individuals with <italic toggle="yes">mut<sup>0</sup></italic> MMA [<xref ref-type="bibr" rid="mma.REF.brassier.2013.106">Brassier et al 2013</xref>]. However, one patient died after developing hepatoblastoma, neurologic deterioration accompanied by CSF lactic acidosis, and multiorgan failure; a second patient developed progressive neurologic symptoms; and two others developed metabolic decompensations post transplant. Long-term follow up is necessary to determine if this is a safe alternative to liver transplantation or liver-kidney transplantation, especially in persons with severe <italic toggle="yes">mut<sup>0</sup></italic> MMA.</p>
          </sec>
        </sec>
        <sec id="mma.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Frequent monitoring of plasma amino acids is necessary to avoid deficiencies of essential amino acids (particularly isoleucine, valine, and methionine) as a result of excessive protein restriction and the development of acrodermatitis-enteropathica-like cutaneous lesions in methylmalonic aciduria, as in other organic acidurias (glutaric aciduria-I) and amino acid disorders (<related-object link-type="booklink" source-id="gene" document-id="msud" document-type="chapter">maple syrup urine disease</related-object>) [<xref ref-type="bibr" rid="mma.REF.de_raeve.1994.416">De Raeve et al 1994</xref>].</p>
          <p>Low plasma amino acids can reflect low natural protein intake, imbalanced intake of branched chain amino acid from use of metabolic formulas, or effects of chronic acidosis on branched chain amino acid metabolism [<xref ref-type="bibr" rid="mma.REF.manoli.2016b.386">Manoli et al 2016b</xref>].</p>
        </sec>
        <sec id="mma.Surveillance">
          <title>Surveillance</title>
          <p>During the first year of life, infants may need to be evaluated as frequently as every week. No guidelines regarding the recommended type or frequency of laboratory testing have been published.</p>
          <p>The following should be monitored on a regular six-month to one-year basis or more frequently if the patient is unstable and requires frequent changes in management:</p>
          <list list-type="bullet">
            <list-item>
              <p>Plasma amino acids</p>
            </list-item>
            <list-item>
              <p>Plasma and urine MMA levels</p>
            </list-item>
            <list-item>
              <p>Serum acylcarnitines and free and total carnitine levels</p>
            </list-item>
            <list-item>
              <p>Chemistry: Na+, K+, CI&#x02013;, glucose, urea, creatinine, bicarbonate, AST, ALT, alkaline phosphatase, bilirubin (T/U), triglycerides, and cholesterol</p>
            </list-item>
            <list-item>
              <p>Liver, kidney, and bone health</p>
            </list-item>
            <list-item>
              <p>Bone marrow indices</p>
            </list-item>
          </list>
          <p>Monitoring of kidney function periodically with creatinine, cystatin-C, and, if available, studies of glomerular filtration rate (GFR) (e.g., iohexol plasma decay), in addition to imaging of the kidneys, will allow for early referral to nephrology and appropriate timing of renal transplantation when needed [<xref ref-type="bibr" rid="mma.REF.vant_hoff.1999.s70">van't Hoff et al 1999</xref>, <xref ref-type="bibr" rid="mma.REF.kruszka.2013.990">Kruszka et al 2013</xref>]. Combined equations based on creatinine and cystatin-C are expected to reflect more accurately the kidney function in this patient population [<xref ref-type="bibr" rid="mma.REF.schwartz.2009.629">Schwartz et al 2009</xref>].</p>
          <p>Regular ophthalmology and audiology evaluations to screen for optic nerve thinning/pallor and hearing loss [Authors, unpublished observations] are recommended.</p>
        </sec>
        <sec id="mma.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p>Fasting. During acute illness, intake of adequate calories is necessary to arrest/prevent decompensation.</p>
            </list-item>
            <list-item>
              <p>Stress</p>
            </list-item>
            <list-item>
              <p>Increased dietary protein</p>
            </list-item>
            <list-item>
              <p>Supplementation with the individual propiogenic amino acids valine and isoleucine, as they directly increase the toxic metabolite load in patients with disordered propionate oxidation [<xref ref-type="bibr" rid="mma.REF.nyhan.1973.539">Nyhan et al 1973</xref>, <xref ref-type="bibr" rid="mma.REF.hauser.2011.47">Hauser et al 2011</xref>, <xref ref-type="bibr" rid="mma.REF.manoli.2016b.386">Manoli et al 2016b</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="mma.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Depending on the genotype and phenotype of the proband, evaluation of sibs at risk should be performed using biochemical testing with treatment instituted as soon as possible if a sib is affected. Molecular genetic testing (if the pathogenic variants in the family are known) or cellular enzymology typically can further confirm the results of biochemical studies. Prenatal diagnosis of at-risk sibs may allow for prompt treatment of affected newborns at the time of delivery.</p>
          <p>See <xref ref-type="sec" rid="mma.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mma.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Oral and intramuscular vitamin B<sub>12</sub> has been administered to women pregnant with a fetus with vitamin B<sub>12</sub>-responsive MMA, resulting in decreased maternal MMA urine output [<xref ref-type="bibr" rid="mma.REF.ampola.1975.313">Ampola et al 1975</xref>, <xref ref-type="bibr" rid="mma.REF.van_der_meer.1990.923">van der Meer et al 1990</xref>]. Despite these observations, maternal vitamin B<sub>12</sub> supplementation for isolated MMA needs further study.</p>
          <p>Despite high maternal MMA levels, fetal growth and development were normal for all reported pregnancies of women with MMA [<xref ref-type="bibr" rid="mma.REF.wasserstein.1999.788">Wasserstein et al 1999</xref>, <xref ref-type="bibr" rid="mma.REF.deodato.2002.133">Deodato et al 2002</xref>].</p>
          <p>Complications observed in pregnancies of women with MMA can include acute decompensation or hyperammonemia, deterioration of renal function, and obstetric complications including preeclampsia, preterm delivery, and c&#x000e6;sarean section [<xref ref-type="bibr" rid="mma.REF.raval.2015.839">Raval et al 2015</xref>].</p>
        </sec>
        <sec id="mma.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Carefully designed clinical studies are required to evaluate the efficacy of antioxidant regimens in patients with MMA.</p>
          <p><bold>Gene therapy</bold>. Preliminary studies in human-derived hepatocytes and animal models of methylmalonic acidemia suggest a potential benefit of gene therapy [<xref ref-type="bibr" rid="mma.REF.chandler.2008.53">Chandler &#x00026; Venditti 2008</xref>, <xref ref-type="bibr" rid="mma.REF.carrillocarrasco.2010.1147">Carrillo-Carrasco et al 2010</xref>, <xref ref-type="bibr" rid="mma.REF.chandler.2010.11">Chandler &#x00026; Venditti 2010</xref>, <xref ref-type="bibr" rid="mma.REF.chandler.2012.617">Chandler &#x00026; Venditti 2012</xref>, <xref ref-type="bibr" rid="mma.REF.s_nac.2012.385">S&#x000e9;nac et al 2012</xref>]. The effect of that therapeutic approach in patients and especially on the long term complications of methylmalonic acidemia remains to be elucidated in appropriate clinical studies.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="mma.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mma.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Isolated methylmalonic acidemia (complete or partial deficiency of the enzyme methylmalonyl-CoA mutase; defect in transport or synthesis of the methylmalonyl-CoA mutase cofactor, adenosyl-cobalamin; and deficiency of the enzyme methylmalonyl-CoA epimerase) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="mma.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry one <italic toggle="yes">MUT</italic>, <italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB, MCEE</italic>, or <italic toggle="yes">MMADHC</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each full sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with isolated methylmalonic acidemia are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">MUT</italic>, <italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB, MCEE</italic>, or <italic toggle="yes">MMADHC</italic>.</p>
          <p><bold>Other family members.</bold> Each full sib of the proband's parents is at a 50% risk of being a carrier for a pathogenic variant in <italic toggle="yes">MUT</italic>, <italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB, MCEE</italic>, or <italic toggle="yes">MMADHC</italic>.</p>
        </sec>
        <sec id="mma.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">MUT</italic>, <italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB, MCEE</italic>, or <italic toggle="yes">MMADHC</italic> pathogenic variants in the family.</p>
          <p>Methods other than molecular genetic testing are not reliable for carrier testing.</p>
        </sec>
        <sec id="mma.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="mma.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on testing at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mma.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal testing for pregnancies at 25% risk for isolated methylmalonic acidemia is possible by:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Molecular genetic testing</bold> if the <italic toggle="yes">MUT</italic>, <italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB, MCEE</italic>, or <italic toggle="yes">MMADHC</italic> pathogenic variants have been identified in an affected family member.</p>
              <p>Note: Due to the limited availability and longer turnaround time for cellular biochemical assays, the preferred method for prenatal diagnosis is molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>The use of fetal cell-free DNA in maternal plasma [<xref ref-type="bibr" rid="mma.REF.gu.2014.564">Gu et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Biochemical testing.</bold> Historically both amniotic fluid measurements and cellular biochemical assays were used:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Amniotic fluid analysis of methylmalonic acid. The absolute positive predictive and negative predictive values of metabolite analysis only have yet to be determined. Elevation of metabolites below the range of affected fetuses can indicate a heterozygous status and should therefore be followed by confirmatory testing in cell studies.</p>
                </list-item>
                <list-item>
                  <p>Incorporation of <sup>14</sup>C propionate and complementation assay of cultured fetal cells obtained by amniocentesis usually performed at approximately 15 to 18 weeks' gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks' gestation. Studies on chorionic villus cells can be false negative and should be followed up by studies on cultured amniocytes [<xref ref-type="bibr" rid="mma.REF.morel.2005.160">Morel et al 2005</xref>]. Confirmation of the diagnosis by the same assay in an affected family member must be obtained before prenatal testing can be performed.</p>
                  <p>Note: For pregnant women not interested in pursuing prenatal diagnosis by amniocentesis or CVS, a urine organic acid test may be helpful since women carrying an affected fetus have been shown to excrete MMA in their urine [<xref ref-type="bibr" rid="mma.REF.ampola.1975.313">Ampola et al 1975</xref>, <xref ref-type="bibr" rid="mma.REF.van_der_meer.1990.923">van der Meer et al 1990</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for families in which the <italic toggle="yes">MUT</italic>, <italic toggle="yes">MMAA</italic>, <italic toggle="yes">MMAB, MCEE</italic>, or <italic toggle="yes">MMADHC</italic> pathogenic variants have been identified.</p>
        </sec>
      </sec>
      <sec id="mma.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mma.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">MMAA</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MMAA</italic> comprises seven exons; the first is non-coding [<xref ref-type="bibr" rid="mma.REF.dobson.2002b.15554">Dobson et al 2002b</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mma" object-id="mma.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 20 pathogenic variants have been described, including missense, nonsense, and splicing variants, deletions, and insertions [<xref ref-type="bibr" rid="mma.REF.dobson.2002a.3361">Dobson et al 2002a</xref>, <xref ref-type="bibr" rid="mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</xref>, <xref ref-type="bibr" rid="mma.REF.yang.2004.329">Yang et al 2004</xref>, <xref ref-type="bibr" rid="mma.REF.merinero.2008.55">Merinero et al 2008</xref>].</p>
        <table-wrap id="mma.T.mmaa_pathogenic_variants_discussed" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">MMAA</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.64C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg22Ter</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_3" rowspan="15" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/26892294">NM_172250.1</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/26892295">NP_758454.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.161G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp54Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.266T&#x0003e;C</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu89Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.283C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln95Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.358C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln120Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.397C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln133Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.433C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg145Ter&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.503delC&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr168MetfsTer9&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.562G&#x0003e;C</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly188Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.650T&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu217Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.653G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly218Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.733+1G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.988C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg330Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1076G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg359Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.592_595delACTG</td>
                <td headers="hd_h_mma.T.mmaa_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr198SerfsTer6</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="mma.TF.3.1">
              <label>1. </label>
              <p>The most common pathogenic variant identified; accounts for 43% of mutated alleles identified in one large study [<xref ref-type="bibr" rid="mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</xref>]. This variant resides on a common haplotype and has also been seen in Spanish individuals [<xref ref-type="bibr" rid="mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</xref>].</p>
            </fn>
            <fn id="mma.TF.3.2">
              <label>2. </label>
              <p>In Japan, a common pathogenic deletion, c.503delC, has been observed [<xref ref-type="bibr" rid="mma.REF.yang.2004.329">Yang et al 2004</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The gene is predicted to encode a protein of 418 amino acids. The predicted gene product possesses a mitochondrial leader sequence and appears to belong to the ArgK protein subfamily of G3E GTPases [<xref ref-type="bibr" rid="mma.REF.leipe.2002.41">Leipe et al 2002</xref>]. While this protein was originally proposed to function in cobalamin entry into the mitochondria [<xref ref-type="bibr" rid="mma.REF.dobson.2002a.3361">Dobson et al 2002a</xref>], it was recently characterized as a metallochaperone GTPase that acts to protect the methylmalonyl-CoA mutase enzyme from oxidative inactivation during catalytic cycles and to facilitate cofactor (adenosylcobalamin) binding [<xref ref-type="bibr" rid="mma.REF.korotkova.2004.13652">Korotkova &#x00026; Lidstrom 2004</xref>, <xref ref-type="bibr" rid="mma.REF.hubbard.2007.31308">Hubbard et al 2007</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The precise biochemical function of the <italic toggle="yes">MMAA</italic> gene product is unknown but suspected to be similar to homologs in bacteria. Missense pathogenic variants appear to fall in evolutionarily conserved residues or consensus splice sites. Environmental, dietary, and (possibly) epigenetic modifiers may operate to define the phenotype in this condition, especially since individuals with homozygous pathogenic variants can exhibit disparate phenotypes [<xref ref-type="bibr" rid="mma.REF.lernerellis.2004.509">Lerner-Ellis et al 2004</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">MMAB</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MMAB</italic> comprises nine exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mma" object-id="mma.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Several missense, nonsense/frameshift, and splice site pathogenic variants have been identified [<xref ref-type="bibr" rid="mma.REF.dobson.2002a.3361">Dobson et al 2002a</xref>, <xref ref-type="bibr" rid="mma.REF.yang.2004.329">Yang et al 2004</xref>, <xref ref-type="bibr" rid="mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</xref>, <xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>]. More than half occurred in exon 7 [<xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>]:</p>
        <p>Two individuals of African American descent with a late presentation (ages 3 and 8 years) both had three <italic toggle="yes">MMAB</italic> pathogenic variants: c.403G&#x0003e;A, c.571C&#x0003e;T, and c.656A&#x0003e;G [<xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>].</p>
        <table-wrap id="mma.T.mmab_pathogenic_variants_discussed" orientation="portrait" position="anchor">
          <label>Table 4. </label>
          <caption>
            <p><italic toggle="yes">MMAB</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.287T&#x0003e;C</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile96Thr</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_3" rowspan="11" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/120432048">
                    <underline>NM_052845.3</underline>
                  </ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/16418349">
                    <underline>NP_443077.1</underline>
                  </ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.291-1G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.403G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala135Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.556C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg186Trp&#x000a0;<sup>1</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.568C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg190Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.569G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg190His</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.571C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg191Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.572G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg191Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.656A&#x0003e;G</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr219Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.197-1G&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.700C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mmab_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln234Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="mma.TF.4.1">
              <label>1. </label>
              <p>The most common pathogenic variant in a large series [<xref ref-type="bibr" rid="mma.REF.lernerellis.2006.219">Lerner-Ellis et al 2006</xref>], accounted for 33% of all alleles and seen exclusively among affected individuals of European descent, was associated with early onset of symptoms (age &#x0003c;1 year).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The gene encodes the 250-amino acid ATP-dependent mitochondrial protein cob(I)alamin adenosyltransferase, an enzyme that transfers the adenosyl group from ATP to Co[+1] balamin [<xref ref-type="bibr" rid="mma.REF.leal.2003.9227">Leal et al 2003</xref>] to form adenosyslcobalamin and shuttles this cofactor to the MUT enzyme. The crystal structure of a bacterial homologue has been determined [<xref ref-type="bibr" rid="mma.REF.saridakis.2004.23646">Saridakis et al 2004</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The reported pathogenic missense variants fall into residues that are evolutionarily conserved [<xref ref-type="bibr" rid="mma.REF.dobson.2002b.15554">Dobson et al 2002b</xref>]. One pathogenic variant destroys a splice site [<xref ref-type="bibr" rid="mma.REF.dobson.2002b.15554">Dobson et al 2002b</xref>, <xref ref-type="bibr" rid="mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</xref>]. Several pathogenic variants have been biochemically characterized [<xref ref-type="bibr" rid="mma.REF.saridakis.2004.23646">Saridakis et al 2004</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">MUT</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MUT</italic> comprises 13 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mma" object-id="mma.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> More than 190 pathogenic variants have been described, including 103 (54%) missense; 27 (14%) nonsense; 18 (9%) splicing; 42 (22%) small insertions/deletions; and one large deletion of exon 12. The pathogenic variants are distributed throughout the entire coding sequence except for exon 1, which is untranslated [<xref ref-type="bibr" rid="mma.REF.crane.1992.385">Crane et al 1992</xref>, <xref ref-type="bibr" rid="mma.REF.crane.1994.42">Crane &#x00026; Ledley 1994</xref>, <xref ref-type="bibr" rid="mma.REF.ogasawara.1994.867">Ogasawara et al 1994</xref>, <xref ref-type="bibr" rid="mma.REF.ledley.1997.1">Ledley &#x00026; Rosenblatt 1997</xref>, <xref ref-type="bibr" rid="mma.REF.adjalla.1998.s248">Adjalla et al 1998</xref>, <xref ref-type="bibr" rid="mma.REF.fuchshuber.2000.179">Fuchshuber et al 2000</xref>, <xref ref-type="bibr" rid="mma.REF.acquaviva.2001.577">Acquaviva et al 2001</xref>, <xref ref-type="bibr" rid="mma.REF.acquaviva.2005.167">Acquaviva et al 2005</xref>, <xref ref-type="bibr" rid="mma.REF.jung.2005.367">Jung et al 2005</xref>, <xref ref-type="bibr" rid="mma.REF.mart_nez.2005.317">Mart&#x000ed;nez et al 2005</xref>, <xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.gradinger.2007.1045">Gradinger et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.lempp.2007.284">Lempp et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.sakamoto.2007.48">Sakamoto et al 2007</xref>, <xref ref-type="bibr" rid="mma.REF.merinero.2008.55">Merinero et al 2008</xref>].</p>
        <p>For a list of pathogenic variants that have been repeatedly identified in diverse populations, click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="mma-MUTalleles.pdf" content-type="local-data">here</inline-supplementary-material> (pdf).</p>
        <p>While some individuals are homozygous for a given pathogenic variant, most are compound heterozygotes. The phenomenon of interallelic complementation makes prediction of genotype/phenotype/enzyme activity difficult because some individuals who have two pathogenic variants can have a <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype in the compound state but a <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype in the homozygous state [<xref ref-type="bibr" rid="mma.REF.janata.1997.1457">Janata et al 1997</xref>, <xref ref-type="bibr" rid="mma.REF.ledley.1997.1">Ledley &#x00026; Rosenblatt 1997</xref>, <xref ref-type="bibr" rid="mma.REF.acquaviva.2005.167">Acquaviva et al 2005</xref>].</p>
        <p>Persons with two truncating pathogenic variants usually have the <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype.</p>
        <p>Nonsense pathogenic variants have been described in the following codons: 7, 18, 23, 31, 54, 84, 117, 121, 135, 152, 156, 161, 224, 228, 284, 342, 403, 413, 414, 426, 429, 451, 467, 474, 494, 511, 544, 581, 589, 688, and 727.</p>
        <p>Only a few of the frequently reported pathogenic variants are seen in homozygous form; p.Arg108Cys, p.Asn219Tyr, and p.Arg369His cause a <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype when homozygous [<xref ref-type="bibr" rid="mma.REF.acquaviva.2001.577">Acquaviva et al 2001</xref>, <xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>], while p.Gly717Val and p.Arg694Trp are associated with a <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype when homozygous [<xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>].</p>
        <p>One case of chromosome 6 paternal isodisomy resulting in <italic toggle="yes">mut<sup>0</sup></italic> MMA and insulin-dependent diabetes mellitus has been reported [<xref ref-type="bibr" rid="mma.REF.abramowicz.1994.418">Abramowicz et al 1994</xref>].</p>
        <p>The <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype is known to be associated mostly, but not exclusively, with pathogenic variants in the cobalamin binding domain of the <italic toggle="yes">mut</italic> protein. The <italic toggle="yes">mut<sup>&#x02013;</sup></italic> enzymatic subtype pathogenic variant plays usually a dominant role when in compound heterozygote state with a <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype pathogenic variant, given a OH-Cbl response in the in vitro assay [<xref ref-type="bibr" rid="mma.REF.lempp.2007.284">Lempp et al 2007</xref>].</p>
        <table-wrap id="mma.T.mut_pathogenic_missense_variants_d" orientation="portrait" position="anchor">
          <label>Table 5. </label>
          <caption>
            <p><italic toggle="yes">MUT</italic> Pathogenic Missense Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mut Enzymatic Subtype (when Homozygous)</th>
                <th id="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut<sup>0</sup></italic>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.19C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln7Ter</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_4" rowspan="27" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/4557766">NM_000255.1</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/4557767">NP_000246.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut<sup>0</sup></italic>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.52C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln18Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut<sup>0</sup></italic>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.91C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg31Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.278G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg93His</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.284C&#x0003e;G</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro95Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.313T&#x0003e;C</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Trp105Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.322C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg108Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.521T&#x0003e;C</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe174Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.572C&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala191Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.607G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly203Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.643G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly215Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.655A&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn219Tyr</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.935G&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly312Val</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1105C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg369Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1106G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg369His</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1280G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly427Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1867G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly623Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>&#x02013;</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.299A&#x0003e;G</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr100Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>&#x02013;</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.691T&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr231Asn</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>&#x02013;</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1097A&#x0003e;G</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn366Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1553T&#x0003e;C</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu518Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1867G&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly623Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">mut<sup>&#x02013;</sup></italic>&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.2054T&#x0003e;G</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu685Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>&#x02013;</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.2080C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg694Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>&#x02013;</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.2099T&#x0003e;A</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Met700Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut<sup>&#x02013;</sup></italic>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.2150G&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly717Val</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <italic toggle="yes">mut</italic>
                  <sup>0</sup>
                </td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.2179C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mut_pathogenic_missense_variants_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg727Ter</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors.&#x000a0;<italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p><italic toggle="yes">mut</italic><sup>0</sup> = <italic toggle="yes">mut</italic><sup>0</sup> enzymatic subtype</p>
            </fn>
            <fn>
              <p><italic toggle="yes">mut</italic><sup>&#x02013;</sup> = <italic toggle="yes">mut</italic><sup>&#x02013;</sup> enzymatic subtype</p>
            </fn>
            <fn>
              <p>NA = not applicable</p>
            </fn>
            <fn id="mma.TF.5.1">
              <label>1. </label>
              <p>Observed in individuals of Hispanic descent.</p>
            </fn>
            <fn id="mma.TF.5.2">
              <label>2. </label>
              <p>
                <xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al [2006]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Methylmalonyl-CoA mutase enzyme, a nuclear-encoded enzyme localized in the mitochondria, exists as a homodimer. The protein comprises 750 amino acids and has an N-terminal mitochondrial leader sequence (residues 1-32) that is removed by the mitochondrial importation and processing machinery. The mitochondrial leader signal is followed by the N-terminal extended segment (residues 33-87), which is involved in subunit interaction. The N-terminal barrel is the substrate-binding domain (residues 88-422) and is attached to the C-terminal adenosylcobalamin-binding domain (residues 578-750) by a long linker region (423-577). The protein contains a mole of adenosylcobalamin per mole of subunit and performs a 1, 2 rearrangement reaction, isomerizing L-methylmalonyl-CoA into succinyl-CoA [<xref ref-type="bibr" rid="mma.REF.fenton.2001">Fenton et al 2001</xref>]. The crystal structure of the human enzyme has been solved [<xref ref-type="bibr" rid="mma.REF.froese.2013.1182">Froese et al 2013</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Only selected pathogenic variants have been studied enzymatically. The methylmalonyl-CoA mutase protein has several functional domains; pathogenic variants have been described in each.</p>
        <p>A mitochondrial leader sequence lies at the amino terminus. Three nonsense pathogenic variants fall into this domain: p.Gln7Ter [<xref ref-type="bibr" rid="mma.REF.acquaviva.2005.167">Acquaviva et al 2005</xref>] and p.Gln18Ter and p.Arg31Ter [<xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>]. One report noted that a truncated protein, likely translated from an internal AUG, arose from the p.Gln18Ter variant. This mutated protein is "mis-targeted" and not functional.</p>
        <p>The putative dimerization domain of the enzyme subunits is adjacent to, but distinct from, the mitochondrial leader sequence.</p>
        <p>The coenzyme-A binding pocket spans the middle of the second exon to the end of the sixth exon. Pathogenic variants that reside in this location, between amino acids 86 and 423, may destroy substrate binding and are predicted to impede catalysis by a variety of mechanisms. Some, such as p.Arg93His, can participate in interallelic complementation. The mechanism underlying this phenomenon is unclear [<xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>].</p>
        <p>A linker domain spanning residues 424-577 separates the C-terminal cobalamin-binding domain. Most of the pathogenic variants identified in this domain are splice-site or nonsense changes and have been associated with <italic toggle="yes">mut<sup>0</sup></italic> enzymatic subtype of methylmalonic acidemia [<xref ref-type="bibr" rid="mma.REF.acquaviva.2005.167">Acquaviva et al 2005</xref>], while the only pathogenic missense variant (c.1553T&#x0003e;C) located in the middle of this segment affects a highly conserved amino acid [<xref ref-type="bibr" rid="mma.REF.worgan.2006.31">Worgan et al 2006</xref>].</p>
        <p>Most of the mut<sup>&#x02013;</sup> enzymatic subtype pathogenic variants reside in the cobalamin binding domain, which is located between amino acids 578 and 750. Some pathogenic variants in this region can display purely K<sub>m</sub> effects, as could be expected for a cofactor binding pathogenic variant, while others affect the K<sub>m</sub> and V<sub>max</sub> [<xref ref-type="bibr" rid="mma.REF.janata.1997.1457">Janata et al 1997</xref>]. This region also contains residues that can participate in interallelic complementation [<xref ref-type="bibr" rid="mma.REF.ledley.1997.1">Ledley &#x00026; Rosenblatt 1997</xref>].</p>
        <p>Detailed functional characterization is available for a small number of missense variants shown to cause (a) reduced protein level due to misfolding, (b) increased thermolability, (c) impaired enzyme activity, and (d) reduced cofactor response in substrate turnover [<xref ref-type="bibr" rid="mma.REF.forny.2014.1449">Forny et al 2014</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">MCEE</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MCEE</italic> comprises four exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mma" object-id="mma.molgen.TA">Table A</related-object>, Gene.</p>
        <p><bold>Pathogenic variants.</bold> After the initial identification of two individuals with methylmalonic aciduria who were homozygous for the p.Arg47Ter pathogenic variant [<xref ref-type="bibr" rid="mma.REF.bikker.2006.640">Bikker et al 2006</xref>, <xref ref-type="bibr" rid="mma.REF.dobson.2006.327">Dobson et al 2006</xref>], an additional four of 229 individuals with elevated MMA of unknown etiology were reported to have a pathogenic variant in <italic toggle="yes">MCEE</italic> [<xref ref-type="bibr" rid="mma.REF.gradinger.2007.1045">Gradinger et al 2007</xref>]. Two persons with decreased [<sup>14</sup>C]propionate incorporation were homozygous for the pathogenic nonsense variant c.139C&#x0003e;T in exon 2. Among 199 persons with normal [<sup>14</sup>C]propionate incorporation, one was homozygous for the novel pathogenic missense variant c.178A&#x0003e;C in exon 2, and two were heterozygous for the novel pathogenic missense variant c.427C&#x0003e;T in exon 3.</p>
        <table-wrap id="mma.T.mcee_pathogenic_variants_discussed" orientation="portrait" position="anchor">
          <label>Table 6. </label>
          <caption>
            <p><italic toggle="yes">MCEE</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.139C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg47Ter</td>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/188035927">NM_032601.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_115990.3">NP_115990.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.178A&#x0003e;C</td>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys60Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.427C&#x0003e;T</td>
                <td headers="hd_h_mma.T.mcee_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg143Cys</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">MCEE</italic> encodes the 176 amino acid enzyme, methylmalonyl-CoA epimerase, which converts of D-methylmalonyl-CoA to L-methylmalonyl-CoA.</p>
        <p><bold>Abnormal gene product</bold>. The pathogenic variants described to date are either missense or nonsense and are predicted to decrease or eliminate function.</p>
        <p>
          <bold>
            <italic toggle="yes">MMADHC</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MMADHC</italic> (formerly <italic toggle="yes">C2orf25)</italic> comprises eight exons and spans 18 kb [<xref ref-type="bibr" rid="mma.REF.coelho.2008.1454">Coelho et al 2008</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mma" object-id="mma.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants in the C-terminal region (exons 3, 4, or 5) that cause a cblD variant 2 only phenotype (isolated methylmalonic aciduria) are listed in <xref ref-type="table" rid="mma.T.isolated_mmaassociated_mmadhc_path">Table 7</xref>.</p>
        <p>Pathogenic missense variants in the N-terminal region (exons 6 and 8) cause cblD variant 1 only phenotype (isolated homocystinuria), while truncating pathogenic variants in exons 5 and 8 and intron 7 cause the classic cblD phenotype (combined homocystinuria and methylmalonic aciduria) [<xref ref-type="bibr" rid="mma.REF.coelho.2008.1454">Coelho et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.miousse.2009.551">Miousse et al 2009</xref>].</p>
        <table-wrap id="mma.T.isolated_mmaassociated_mmadhc_path" orientation="portrait" position="anchor">
          <label>Table 7. </label>
          <caption>
            <p>Isolated MMA-Associated <italic toggle="yes">MMADHC</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.57_64delCTCTTTAG</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser20Ter<break/>(Cys19fsTer20)</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_3" rowspan="7" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/215422307">NM_015702.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/7661548">NP_056517.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.60_61insAT<break/>(60insAT)</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu21IlefsTer2<break/>(Leu20fsTer21)</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.133dupG</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg45GlyfsTer15</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.160C&#x0003e;T</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg54Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.228dupG</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn77GlufsTer5</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.307_324dup</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu103_Ser108dup</td>
              </tr>
              <tr>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.455dupC</td>
                <td headers="hd_h_mma.T.isolated_mmaassociated_mmadhc_path_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys153MetfsTer10<break/>(Thr152fsTer162)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="mma.TF.7.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The <italic toggle="yes">MMADHC</italic> product is predicted to have 296 amino acids with a calculated molecular mass of 32.8 kd. It shows homology to the putative ATPase component of a bacterial ABC transporter. There is an N-terminal mitochondrial leader sequence and a predicted B<sub>12</sub> binding sequence [<xref ref-type="bibr" rid="mma.REF.coelho.2008.1454">Coelho et al 2008</xref>] and MMADHC has been localized to both the cytoplasm and mitochondria in vitro [<xref ref-type="bibr" rid="mma.REF.mah.2013.112">Mah et al 2013</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The <italic toggle="yes">cblD</italic>-MMA mutated alleles (c.57_64delCTCTTTAG, c.60_61insAT, c.133dupG, c.160C&#x0003e;T, and c.228dupG) were expressed in an immortalized cell line from a patient with the <italic toggle="yes">cblD</italic>-combined phenotype and were able to rescue MeCbl synthesis [<xref ref-type="bibr" rid="mma.REF.stucki.2012.1410">Stucki et al 2012</xref>]. This work showed that additional reinitiation codons at Met62 and Met116 result in shorter functional <italic toggle="yes">cblD</italic> proteins that lack the putative mitochondrial leader sequence but allow for normal methylcobalamin synthesis [<xref ref-type="bibr" rid="mma.REF.coelho.2008.1454">Coelho et al 2008</xref>, <xref ref-type="bibr" rid="mma.REF.stucki.2012.1410">Stucki et al 2012</xref>]. Each patient with <italic toggle="yes">cblD</italic>-MMA reported to date appears to have at least one pathogenic variant causing premature stop towards the N terminus of the enzyme.</p>
      </sec>
      <sec id="mma.References">
        <title>References</title>
        <sec id="mma.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mma.Literature_Cited.reflist0">
            <ref id="mma.REF.abramowicz.1994.418">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abramowicz</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorchy</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parma</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duprez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledley</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Courtens</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vamos</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Isodisomy of chromosome 6 in a newborn with methylmalonic acidemia and agenesis of pancreatic beta cells causing diabetes mellitus.</article-title>
                <source>J Clin Invest.</source>
                <year>1994</year>
                <volume>94</volume>
                <fpage>418</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">7913714</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.acquaviva.2001.577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Acquaviva</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callebaut</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guffon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier de Baulny</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aydin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porquet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elion</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>N219Y, a new frequent mutation among mut(o) forms of methylmalonic acidemia in Caucasian patients.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>9</volume>
                <fpage>577</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11528502</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.acquaviva.2005.167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Acquaviva</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callebaut</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koskas</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porquet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elion</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut(o) and mut- forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene.</article-title>
                <source>Hum Mutat</source>
                <volume>25</volume>
                <fpage>167</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">15643616</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.adjalla.1998.s248">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Adjalla</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosack</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matiaszuk</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>A common mutation among blacks with mut- methylmalonic aciduria.</article-title>
                <source>Hum Mutat.</source>
                <year>1998</year>
                <supplement>Suppl 1</supplement>
                <fpage>S248</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">9452100</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ah_mew.2010.e208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ah Mew</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCarter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daikhin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissim</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yudkoff</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuchman</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia.</article-title>
                <source>Pediatrics.</source>
                <year>2010</year>
                <volume>126</volume>
                <fpage>e208</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">20566609</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.alfares.2011.602">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alfares</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunez</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Thihli</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melan&#x000e7;on</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anastasio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ha</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype.</article-title>
                <source>J Med Genet.</source>
                <year>2011</year>
                <volume>48</volume>
                <fpage>602</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21785126</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.alowain.2004.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Owain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freehauf</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kappy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Growth hormone deficiency associated with methylmalonic acidemia.</article-title>
                <source>J Pediatr Endocrinol Metab.</source>
                <year>2004</year>
                <volume>17</volume>
                <fpage>239</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15055362</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ampola.1975.313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ampola</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal therapy of a patient with vitamin-B12-responsive methylmalonic acidemia.</article-title>
                <source>N Engl J Med.</source>
                <year>1975</year>
                <volume>293</volume>
                <fpage>313</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">239344</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.atkuri.2009.3941">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Atkuri</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzenberg</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzenberg</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia.</article-title>
                <source>Proc Natl Acad Sci USA</source>
                <volume>106</volume>
                <fpage>3941</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19223582</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.bain.1995.850">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bain</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nussey</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chalmers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Use of human somatotrophin in the treatment of a patient with methylmalonic aciduria.</article-title>
                <source>Eur J Pediatr</source>
                <volume>154</volume>
                <fpage>850</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">8529687</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.baker.2015.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>MRI characteristics of globus pallidus infarcts in isolated methylmalonic acidemia.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2015</year>
                <volume>36</volume>
                <fpage>194</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">25190203</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.baumgarter.1995.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baumgarter</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viardot</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>1995</year>
                <volume>18</volume>
                <issue>2</issue>
                <fpage>138</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">7564229</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.baumgartner.2014.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haliloglu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huemer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochuli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Assoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballhausen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;nert</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honzik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>130</fpage>
                <pub-id pub-id-type="pmid">25205257</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.bikker.2006.640">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bikker</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abeling</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waterham</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanders</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duran</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A homozygous nonsense mutation in the methylmalonyl-CoA epimerase gene (MCEE) results in mild methylmalonic aciduria.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>640</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16752391</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.brassier.2013.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brassier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottolenghi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krug</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cosson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbier</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desguerre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbit</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aigrain</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guest</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>106</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">23751327</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.brown.1984.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholem</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bankier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danks</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Malonyl coenzyme A decarboxylase deficiency.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>7</volume>
                <fpage>21</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">6145813</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.carrillocarrasco.2010.1147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandrasekaran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Liver-directed recombinant adeno-associated viral gene delivery rescues a lethal mouse model of methylmalonic acidemia and provides long-term phenotypic correction.</article-title>
                <source>Hum Gene Ther.</source>
                <year>2010</year>
                <volume>21</volume>
                <fpage>1147</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20486773</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.carrozzo.2007.862">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrozzo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steuerwald</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucioli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Giandomenico</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschini</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piemonte</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodenburg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Rooij</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermunt-de Koning</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>862</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17301081</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.celiker.2009.640">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Celiker</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chawla</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Congenital B12 deficiency following maternal gastric bypass.</article-title>
                <source>J Perinatol.</source>
                <year>2009</year>
                <volume>29</volume>
                <fpage>640</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19710657</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chace.2001.2040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chace</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiPerna</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalas</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>EW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.</article-title>
                <source>Clin Chem</source>
                <volume>47</volume>
                <fpage>2040</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11673377</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chakrapani.2002.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivakumar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Metabolic stroke in methylmalonic acidemia five years after liver transplantation.</article-title>
                <source>J Pediatr</source>
                <volume>140</volume>
                <fpage>261</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11865284</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chambliss.2000.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chambliss</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rylance</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollitt</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2000</year>
                <volume>23</volume>
                <fpage>497</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">10947204</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chan.2015.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mascarenhas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boles</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerkar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genyk</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venkatramani</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Hepatoblastoma in a patient with methylmalonic aciduria.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2015</year>
                <volume>167A</volume>
                <fpage>635</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25691417</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chandler.2007.64">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stabler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaestner</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kazazian</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.</article-title>
                <source>BMC Med Genet</source>
                <volume>8</volume>
                <fpage>64</fpage>
                <pub-id pub-id-type="pmid">17937813</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chandler.2008.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Adenovirus-mediated gene delivery rescues a neonatal lethal murine model of mut(0) methylmalonic acidemia.</article-title>
                <source>Hum Gene Ther</source>
                <volume>19</volume>
                <fpage>53</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18052792</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chandler.2010.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy.</article-title>
                <source>Mol Ther.</source>
                <volume>18</volume>
                <fpage>11</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19861951</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chandler.2012.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA).</article-title>
                <source>Mol Genet Metab.</source>
                <year>2012</year>
                <volume>107</volume>
                <fpage>617</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23046887</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chandler.2009.1252">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerfas</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mitochondrial dysfunction in mut methylmalonic acidemia.</article-title>
                <source>FASEB J</source>
                <volume>23</volume>
                <fpage>1252</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">19088183</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.chang.2000.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hou</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ni</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Metabolic disorders mimicking Reye's syndrome.</article-title>
                <source>J Formos Med Assoc</source>
                <volume>99</volume>
                <fpage>295</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10870312</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ciani.2000.2119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ciani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zammarchi</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Lethal late onset cblB methylmalonic aciduria.</article-title>
                <source>Crit Care Med</source>
                <volume>28</volume>
                <fpage>2119</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10890676</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.clothier.2011.695">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clothier</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preece</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulton</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <article-title>Renal transplantation in a boy with methylmalonic acidaemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2011</year>
                <volume>34</volume>
                <fpage>695</fpage>
                <lpage>700</lpage>
                <pub-id pub-id-type="pmid">21416195</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.coelho.2012.1152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miousse</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>du Moulin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frapolli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robenek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;hne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mengel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutsch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>1152</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22922874</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.coelho.2008.1454">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbold</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Gene identification for the cblD defect of vitamin B12 metabolism.</article-title>
                <source>N Engl J Med.</source>
                <volume>358</volume>
                <fpage>1454</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">18385497</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.coman.2006.270">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McTaggart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Renal transplantation in a 14-year-old girl with vitamin B12-responsive cblA-type methylmalonic acidaemia.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2006</year>
                <volume>21</volume>
                <fpage>270</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16247646</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.cosson.2008.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cosson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacaille</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannnopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guest</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verkarre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chr&#x000e9;tien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Keyzer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonic aciduria.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2008</year>
                <volume>95</volume>
                <fpage>107</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18676166</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.coulombe.1981.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coulombe</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Massachusetts Metabolic Disorders Screening Program. II. Methylmalonic aciduria.</article-title>
                <source>Pediatrics.</source>
                <year>1981</year>
                <volume>67</volume>
                <fpage>26</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">7243433</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.crane.1992.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crane</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledley</surname>
                    <given-names>FD</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Cloning and expression of a mutant methylmalonyl coenzyme A mutase with altered cobalamin affinity that causes mut- methylmalonic aciduria.</article-title>
                <source>J Clin Invest.</source>
                <volume>89</volume>
                <fpage>385</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">1346616</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.crane.1994.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crane</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledley</surname>
                    <given-names>FD</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Clustering of mutations in methylmalonyl CoA mutase associated with mut- methylmalonic acidemia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>55</volume>
                <fpage>42</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">7912889</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dangio.1991.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>D'Angio</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dillon</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Renal tubular dysfunction in methylmalonic acidaemia.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>150</volume>
                <fpage>259</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">2029917</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.de_baulny.2005.415">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Baulny</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigal</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saudubray</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Methylmalonic and propionic acidaemias: management and outcome.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>28</volume>
                <fpage>415</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15868474</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.de_keyzer.2009.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Keyzer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoist</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batteux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacaille</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubert</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chr&#x000e9;tien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chadefeaux-Vekemans</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Multiple OXPHOS deficiency in the liver, kidney, heart and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria.</article-title>
                <source>Pediatr Res</source>
                <volume>66</volume>
                <fpage>91</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19342984</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.de_raeve.1994.416">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Raeve</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Meirleir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenplas</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerlo</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Acrodermatitis enteropathica-like cutaneous lesions in organic aciduria.</article-title>
                <source>J Pediatr</source>
                <volume>124</volume>
                <fpage>416</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8120711</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.deodato.2002.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boenzi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiocco</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Successful pregnancy in a woman with mut- methylmalonic acidaemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2002</year>
                <volume>25</volume>
                <fpage>133</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12118529</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dietzen.2009.1615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dietzen</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitley</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhead</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannon</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garg</surname>
                    <given-names>UC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary.</article-title>
                <source>Clin Chem.</source>
                <year>2009</year>
                <volume>55</volume>
                <fpage>1615</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">19574465</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dionisivici.2006.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deodato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;schinger</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhead</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcken</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>29</volume>
                <fpage>383</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16763906</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dobson.2006.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gradinger</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemieux</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belair</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Homozygous nonsense mutation in the MCEE gene and siRNA suppression of methylmalonyl-CoA epimerase expression: a novel cause of mild methylmalonic aciduria.</article-title>
                <source>Mol Genet Metab</source>
                <volume>88</volume>
                <fpage>327</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">16697227</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dobson.2002a.3361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kadir</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2002a</year>
                <article-title>Identification of the gene responsible for the cblB complementation group of vitamin B12-dependent methylmalonic aciduria.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>3361</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12471062</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dobson.2002b.15554">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dore</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>99</volume>
                <fpage>15554</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12438653</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.dudley.1998.564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dudley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tizard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGraw</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Benign methylmalonic acidemia in a sibship with distal renal tubular acidosis.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>12</volume>
                <fpage>564</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9761355</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.elpeleg.2005.1081">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hershkovitz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bondi-Rubinstein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagnamenta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eshhar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saada</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.</article-title>
                <source>Am J Hum Genet</source>
                <volume>76</volume>
                <fpage>1081</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15877282</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.fenton.2001">
              <mixed-citation publication-type="book">Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. New York, NY: McGraw-Hill. 2001:2165-92.</mixed-citation>
            </ref>
            <ref id="mma.REF.forny.2014.1449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froese</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Functional characterization and categorization of missense mutations that cause methylmalonyl-CoA mutase (MUT) deficiency.</article-title>
                <source>Hum Mutat.</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>1449</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">25125334</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.fowler.2008.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Causes and diagnostic approach to methylmalonic acidurias.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>31</volume>
                <fpage>350</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18563633</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.froese.2013.1182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Froese</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forouhar</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vollmar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lew</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neely</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seetharaman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acton</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everett</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puranik</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savitsky</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krojer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilka</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiyani</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Delft</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allerston</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spagnolo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gileadi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montelione</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oppermann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tong</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Crystal structures of malonyl-coenzyme A decarboxylase provide insights into its catalytic mechanism and disease-causing mutations.</article-title>
                <source>Structure.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>1182</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">23791943</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.fuchshuber.2000.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fuchshuber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mucha</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vollmer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrandt</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>mut0 methylmalonic acidemia: eleven novel mutations of the methylmalonyl CoA mutase including a deletion-insertion mutation.</article-title>
                <source>Hum Mutat.</source>
                <volume>16</volume>
                <fpage>179</fpage>
                <pub-id pub-id-type="pmid">10923046</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.giorgio.1976.310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giorgio</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trowbridge</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boone</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patten</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>1976</year>
                <article-title>Methylmalonic aciduria without vitamin B12 deficiency in an adult sibship.</article-title>
                <source>N Engl J Med</source>
                <volume>295</volume>
                <fpage>310</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">6909</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.gradinger.2007.1045">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gradinger</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;lair</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worgan</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavall&#x000e9;e</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roquis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Atypical methylmalonic aciduria: frequency of mutations in the methylmalonyl CoA epimerase gene (MCEE).</article-title>
                <source>Hum Mutat.</source>
                <year>2007</year>
                <volume>28</volume>
                <fpage>1045</fpage>
                <pub-id pub-id-type="pmid">17823972</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.grange.1994.311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grange</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finlay</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Nutritional vitamin B12 deficiency in a breastfed infant following maternal gastric bypass.</article-title>
                <source>Pediatr Hematol Oncol.</source>
                <year>1994</year>
                <volume>11</volume>
                <fpage>311</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8060815</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.gu.2014.564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koh</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumenfeld</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Sayed</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudgins</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintz</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quake</surname>
                    <given-names>SR</given-names>
                  </name>
                </person-group>
                <article-title>Noninvasive prenatal diagnosis in a fetus at risk for methylmalonic acidemia.</article-title>
                <source>Genet Med.</source>
                <year>2014</year>
                <volume>16</volume>
                <fpage>564</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24406457</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.guerramoreno.2003.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerra-Moreno</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrios</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santiago-Borrero</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <article-title>Severe neutropenia in an infant with methylmalonic acidemia.</article-title>
                <source>Bol Asoc Med P R.</source>
                <year>2003</year>
                <volume>95</volume>
                <fpage>17</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12898746</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.harting.2008.368">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harting</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seitz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwickler</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porto</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Looking beyond the basal ganglia: the spectrum of MRI changes in methylmalonic acidaemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>31</volume>
                <fpage>368</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">18470632</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.hauser.2011.47">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graf</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Variable dietary management of methylmalonic acidemia: metabolic and energetic correlations.</article-title>
                <source>Am J Clin Nutr.</source>
                <year>2011</year>
                <volume>93</volume>
                <fpage>47</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">21048060</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.heidenreich.1988.1022">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heidenreich</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hainline</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillman</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus.</article-title>
                <source>J Pediatr</source>
                <volume>113</volume>
                <fpage>1022</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">3193307</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.h_rster.2007.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viardot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garbade</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB).</article-title>
                <source>Pediatr Res.</source>
                <volume>62</volume>
                <fpage>225</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">17597648</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.hsui.2003.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hsui</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chien</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwu</surname>
                    <given-names>WL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Living-related liver transplantation for methylmalonic acidemia: report of one case.</article-title>
                <source>Acta Paediatr Taiwan</source>
                <volume>44</volume>
                <fpage>171</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14521026</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.hubbard.2007.31308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hubbard</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padovani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labunska</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahlstedt</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerjee</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drennan</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Crystal structure and mutagenesis of the metallochaperone MeaB: insight into the causes of methylmalonic aciduria.</article-title>
                <source>J Biol Chem</source>
                <volume>282</volume>
                <fpage>31308</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">17728257</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.iles.1986.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iles</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chalmers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hind</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Methylmalonic aciduria and propionic acidaemia studied by proton nuclear magnetic resonance spectroscopy.</article-title>
                <source>Clin Chim Acta</source>
                <volume>161</volume>
                <fpage>173</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">3802528</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.inoue.1981.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krieger</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarnaik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravindranath</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fracassa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ottenbreit</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Inhibition of bone marrow stem cell growth in vitro by methylmalonic acid: a mechanism for pancytopenia in a patient with methylmalonic acidemia.</article-title>
                <source>Pediatr Res.</source>
                <year>1981</year>
                <volume>15</volume>
                <fpage>95</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7254944</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.janata.1997.1457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Janata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kogekar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenton</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Expression and kinetic characterization of methylmalonyl-CoA mutase from patients with the mut- phenotype: evidence for naturally occurring interallelic complementation.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1457</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">9285782</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.jung.2005.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryu</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation analysis of the MCM gene in Korean patients with MMA.</article-title>
                <source>Mol Genet Metab</source>
                <volume>84</volume>
                <fpage>367</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">15781199</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.kahler.1994.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahler</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherwood</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woolf</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawless</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaritsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonham</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durie</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Pancreatitis in patients with organic acidemias.</article-title>
                <source>J Pediatr</source>
                <volume>124</volume>
                <fpage>239</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">8301430</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.kaplan.2006.322">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ficicioglu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazur</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmieri</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Liver transplantation is not curative for methylmalonic acidopathy caused by methylmalonyl-CoA mutase deficiency.</article-title>
                <source>Mol Genet Metab</source>
                <volume>88</volume>
                <fpage>322</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16750411</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.karth.2012.398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karth</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costakos</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Bilateral central retinal artery occlusions in an infant with hyperhomocysteinemia.</article-title>
                <source>J AAPOS.</source>
                <year>2012</year>
                <volume>16</volume>
                <fpage>398</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">22819238</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.kasahara.2006.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horikawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uemoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibata</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuroda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honna</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saeki</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Current role of liver transplantation for methylmalonic acidemia: a review of the literature.</article-title>
                <source>Pediatr Transplant</source>
                <volume>10</volume>
                <fpage>943</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17096763</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.kayler.2002.295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kayler</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merion</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sung</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Punch</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudich</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turcotte</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>DA</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Holmes</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magee</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Long-term survival after liver transplantation in children with metabolic disorders.</article-title>
                <source>Pediatr Transplant</source>
                <volume>6</volume>
                <fpage>295</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">12234269</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.k_lker.2015a.1041">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazorla</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teles</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bari&#x00107;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augoustides-Savvopoulou</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksglaede</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avram</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blasco-Alonso</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>I Saladelafont EC, Couce ML, de Meirleir L, Dobbelaere D, Dvorakova V, Furlan F, Gleich F, Gradowska W, Gr&#x000fc;newald S, Jalan A, H&#x000e4;berle J, Haege G, Lachmann R, Laemmle A, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, M&#x000fc;hlhausen C, de Baulny HO, Ortez C, Pe&#x000f1;a-Quintana L, Ramad&#x0017e;a DP, Rodrigues E, Scholl-B&#x000fc;rgi S, Sokal E, Staufner C, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Burgard P. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2015a</year>
                <volume>38</volume>
                <fpage>1041</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">25875215</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.k_lker.2015b.1059">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valayannopoulos</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykut-Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wijburg</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teles</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bari&#x00107;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoux</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avram</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blasco-Alonso</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boy</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrapani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cort&#x000e8;s</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saladelafont</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couce</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Meirleir</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobbelaere</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furlan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gradowska</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honzik</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ioannou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jalan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;berle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haege</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langereis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Lonlay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;hlhausen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Baulny</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortez</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedr&#x000f3;n</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pintos-Morell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pena-Quintana</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramad&#x0017e;a</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodrigues</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholl-B&#x000fc;rgi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sokal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summar</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinera</surname>
                    <given-names>IV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Garcia Cazorla A. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2015b</year>
                <month>Nov</month>
                <volume>38</volume>
                <issue>6</issue>
                <fpage>1059</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">25875216</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.korf.1986.364">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korf</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallman</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <year>1986</year>
                <article-title>Bilateral lucency of the globus pallidus complicating methylmalonic acidemia.</article-title>
                <source>Ann Neurol</source>
                <volume>20</volume>
                <fpage>364</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">3767321</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.korotkova.2004.13652">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Korotkova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lidstrom</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>MeaB is a component of the methylmalonyl-CoA mutase complex required for protection of the enzyme from inactivation.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>13652</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14734568</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.kruszka.2013.990">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kruszka</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopp</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Renal growth in isolated methylmalonic acidemia.</article-title>
                <source>Genet Med.</source>
                <year>2013</year>
                <volume>15</volume>
                <fpage>990</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23639900</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ktena.2015a.2075">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ktena</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Delineating the spectrum of impairments, disabilities, and rehabilitation needs in methylmalonic acidemia (MMA).</article-title>
                <source>Am J Med Genet A.</source>
                <year>2015a</year>
                <month>Sep</month>
                <volume>167A</volume>
                <issue>9</issue>
                <fpage>2075</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">25959030</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ktena.2015b.847">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ktena</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramstad</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannes</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Propofol administration in patients with methylmalonic acidemia and intracellular cobalamin metabolism disorders: a review of theoretical concerns and clinical experiences in 28 patients.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2015b</year>
                <volume>38</volume>
                <fpage>847</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">25985870</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.la_marca.2008.s395">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>la Marca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malvagia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casetta</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zammarchi</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2008</year>
                <volume>31</volume>
                <supplement>Suppl 2</supplement>
                <fpage>S395</fpage>
                <lpage>404</lpage>
                <pub-id pub-id-type="pmid">18956250</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.leal.2003.9227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leal</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kima</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bobik</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of the human and bovine ATP:Cob(I)alamin adenosyltransferase cDNAs based on complementation of a bacterial mutant.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>9227</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">12514191</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ledley.1984.1015">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ledley</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benjamin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Benign methylmalonic aciduria.</article-title>
                <source>N Engl J Med.</source>
                <year>1984</year>
                <volume>311</volume>
                <fpage>1015</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6148691</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ledley.1997.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ledley</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations.</article-title>
                <source>Hum Mutat</source>
                <volume>9</volume>
                <fpage>1</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8990001</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.leipe.2002.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leipe</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>YI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koonin</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aravind</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Classification and evolution of P-loop GTPases and related ATPases.</article-title>
                <source>J Mol Biol.</source>
                <volume>317</volume>
                <fpage>41</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11916378</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lempp.2007.284">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lempp</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegenthaler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalonic aciduria: identification of seven novel mutations.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>90</volume>
                <fpage>284</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">17113806</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.leonard.1997.s67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Stable isotope studies in propionic and methylmalonic acidaemia.</article-title>
                <source>Eur J Pediatr</source>
                <volume>156</volume>
                <fpage>S67</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9266219</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.leonard.2003.s21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vijayaraghavan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The impact of screening for propionic and methylmalonic acidaemia.</article-title>
                <source>Eur J Pediatr</source>
                <volume>162</volume>
                <fpage>S21</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14586648</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lernerellis.2004.509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirone</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leclerc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dore</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepage</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in the MMAA gene in patients with the cblA disorder of vitamin B12 metabolism.</article-title>
                <source>Hum Mutat</source>
                <volume>24</volume>
                <fpage>509</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">15523652</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lernerellis.2006.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lerner-Ellis</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gradinger</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirone</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villeneuve</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobson</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montpetit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepage</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutation and biochemical analysis of patients belonging to the cblB complementation class of vitamin B12-dependent methylmalonic aciduria.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>87</volume>
                <fpage>219</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">16410054</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lindner.2008.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdoh</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgard</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Newborn screening for methylmalonic acidurias--optimization by statistical parameter combination.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>31</volume>
                <fpage>379</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">18563635</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lubrano.2007.1209">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lubrano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Travasso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raggi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barsotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carducci</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berloco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Renal transplant in methylmalonic acidemia: could it be the best option? Report on a case at 10 years and review of the literature.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2007</year>
                <volume>22</volume>
                <fpage>1209</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17401587</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lubrano.2013.2067">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lubrano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Methylmalonic acidemia and kidney transplantation.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>2067</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23793882</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.lubrano.2001.848">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lubrano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scoppi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barsotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Travasso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scateni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cristaldi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castello</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Kidney transplantation in a girl with methylmalonic acidemia and end stage renal failure.</article-title>
                <source>Pediatr Nephrol</source>
                <volume>16</volume>
                <fpage>848</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">11685586</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.macfarland.2015.1840">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>MacFarland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartung</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Pancytopenia in a patient with methylmalonic acidemia.</article-title>
                <source>Blood.</source>
                <year>2015</year>
                <volume>125</volume>
                <fpage>1840</fpage>
                <pub-id pub-id-type="pmid">25927084</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.mah.2013.112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mah</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deme</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulton</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Subcellular location of MMACHC and MMADHC, two human proteins central to intracellular vitamin B(12) metabolism.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2013</year>
                <volume>108</volume>
                <fpage>112</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23270877</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.manoli.2016a.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myles</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morton</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency.</article-title>
                <source>Genet Med.</source>
                <year>2016a</year>
                <month>Apr</month>
                <volume>18</volume>
                <issue>4</issue>
                <fpage>396</fpage>
                <lpage>404</lpage>
                <pub-id pub-id-type="pmid">26270766</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.manoli.2016b.386">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myles</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shchelochkov</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 1: isolated methylmalonic acidemias.</article-title>
                <source>Genet Med.</source>
                <year>2016b</year>
                <month>Apr</month>
                <volume>18</volume>
                <issue>4</issue>
                <fpage>386</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">26270765</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.manoli.2013.13552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sysol</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houillier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garone</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerfas</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cusmano-Ozog</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trivedi</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Asab</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsokos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elkahloun</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnermann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>13552</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23898205</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.marble.2008.731">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marble</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khanfar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <article-title>Neonatal vitamin B12 deficiency secondary to maternal subclinical pernicious anemia: identification by expanded newborn screening.</article-title>
                <source>J Pediatr.</source>
                <year>2008</year>
                <volume>152</volume>
                <fpage>731</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18410783</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.marcadier.2013.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marcadier</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pohl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dirbashi</surname>
                    <given-names>OY</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>Majewski J, Ferdinandusse S, Wanders RJ, Bulman DE, Boycott KM, Chakraborty P, Geraghty MT. Mutations in ALDH6A1 encoding methylmalonate semialdehyde dehydrogenase are associated with dysmyelination and transient methylmalonic aciduria.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>98</fpage>
                <pub-id pub-id-type="pmid">23835272</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.martens.2002.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martens</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Meer</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spaapen</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Unexplained familial benign methylmalonic aciduria.</article-title>
                <source>Eur J Pediatr</source>
                <volume>161</volume>
                <fpage>219</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12014390</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.martinez_alvarez.2016.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martinez Alvarez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jameson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parry</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Optic neuropathy in methylmalonic acidemia and propionic acidemia.</article-title>
                <source>Br J Ophthalmol.</source>
                <year>2016</year>
                <volume>100</volume>
                <fpage>98</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">26209586</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.mart_nez.2005.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinc&#x000f3;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2005</year>
                <volume>84</volume>
                <fpage>317</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">15781192</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.matern.2007.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matern</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tortorelli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oglesbee</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavrilov</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007).</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>30</volume>
                <fpage>585</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17643193</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.matsui.1983.857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>LE</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>The natural history of the inherited methylmalonic acidemias.</article-title>
                <source>N Engl J Med</source>
                <volume>308</volume>
                <fpage>857</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">6132336</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.mc_guire.2009.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mc Guire</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parikh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <article-title>Profiling of oxidative stress in patients with inborn errors of metabolism.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2009</year>
                <volume>98</volume>
                <fpage>173</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">19604711</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.mcguire.2011.e142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hull</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Misra</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smithers</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feins</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jenkins</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillehei</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmon</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonas</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>HB</given-names>
                  </name>
                </person-group>
                <article-title>Combined en bloc liver-double kidney transplantation in an infant with IVC thrombosis.</article-title>
                <source>Pediatr Transplant.</source>
                <year>2011</year>
                <volume>15</volume>
                <fpage>E142</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20412506</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.merinero.2008.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Merinero</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinc&#x000f3;n</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desviat</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sala</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldamiz-Echevarr&#x000ed;a</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornejo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Toro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahfoud</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Pardo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedr&#x000f3;n</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pe&#x000f1;a-Quintana</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pourfarzam</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ugarte</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group.</article-title>
                <source>J Inherit Metab Dis.</source>
                <volume>31</volume>
                <fpage>55</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">17957493</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.miousse.2009.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miousse</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rupar</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crombez</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilain</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee-Messer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Clinical and molecular heterogeneity in patients with the cblD inborn error of metabolism.</article-title>
                <source>J Pediatr</source>
                <volume>154</volume>
                <fpage>551</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19058814</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.morava.2009.438">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steuerwald</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrozzo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kluijtmans</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joensen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionisi-Vici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children.</article-title>
                <source>Mitochondrion.</source>
                <volume>9</volume>
                <fpage>438</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19666145</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.morel.2005.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport.</article-title>
                <source>Mol Genet Metab.</source>
                <volume>86</volume>
                <fpage>160</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16150626</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.morioka.2007.2782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morioka</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasahara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horikawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukuda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Efficacy of living donor liver transplantation for patients with methylmalonic acidemia.</article-title>
                <source>Am J Transplant</source>
                <volume>7</volume>
                <fpage>2782</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17908273</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.nagarajan.2005.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagarajan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millan</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarwal</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <article-title>Management of methylmalonic acidaemia by combined liver-kidney transplantation.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2005</year>
                <volume>28</volume>
                <fpage>517</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15902554</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.nicolaides.1998.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicolaides</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Neurological outcome of methylmalonic acidaemia.</article-title>
                <source>Arch Dis Child</source>
                <volume>78</volume>
                <fpage>508</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9713004</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.niemi.2015.1455">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niemi</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krueger</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baugh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonham</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concepcion</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esquivel</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enns</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>Treatment of methylmalonic acidemia by liver or combined liver-kidney transplantation.</article-title>
                <source>J Pediatr.</source>
                <year>2015</year>
                <month>Jun</month>
                <volume>166</volume>
                <issue>6</issue>
                <fpage>1455</fpage>
                <lpage>61.e1</lpage>
                <pub-id pub-id-type="pmid">25771389</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.nyhan.1973.539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nyhan</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ando</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rennert</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julius</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>Response to dietary therapy in B 12 unresponsive methylmalonic acidemia.</article-title>
                <source>Pediatrics.</source>
                <year>1973</year>
                <volume>51</volume>
                <fpage>539</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">4707869</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.nyhan.2002.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nyhan</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gargus</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selby</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver.</article-title>
                <source>Eur J Pediatr</source>
                <volume>161</volume>
                <fpage>377</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12111189</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.oberholzer.1967.492">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oberholzer</surname>
                    <given-names>VG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgess</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>WF</given-names>
                  </name>
                </person-group>
                <year>1967</year>
                <article-title>Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis.</article-title>
                <source>Arch Dis Child</source>
                <volume>42</volume>
                <fpage>492</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">6061291</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ogasawara.1994.867">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ogasawara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikami</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narisawa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Identification of two novel mutations in the methylmalonyl-CoA mutase gene with decreased levels of mutant mRNA in methylmalonic acidemia.</article-title>
                <source>Hum Mol Genet</source>
                <volume>3</volume>
                <fpage>867</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">7951229</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.oshea.2012.e1541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O'Shea</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pao</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snow</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Neurocognitive phenotype of isolated methylmalonic acidemia.</article-title>
                <source>Pediatrics.</source>
                <year>2012</year>
                <volume>129</volume>
                <fpage>e1541</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">22614770</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ostergaard.2007.853">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ostergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorensen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faeroe</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thorgrimsson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibrand</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>853</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">17287286</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.pangilinan.2010.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pangilinan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>VanderMeer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molloy</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troendle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conley</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirke</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeira</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quadros</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brody</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects.</article-title>
                <source>J Med Genet.</source>
                <year>2010</year>
                <volume>47</volume>
                <fpage>677</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">20577008</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.pela.2006.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pela</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasperini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Hyperkalemia after acute metabolic decompensation in two children with vitamin B12-unresponsive methylmalonic acidemia and normal renal function.</article-title>
                <source>Clin Nephrol.</source>
                <volume>66</volume>
                <fpage>63</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16878438</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.pinarsueiro.2010.s199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pinar-Sueiro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Fern&#x000e1;ndez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lage-Medina</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldamiz-Echevarria</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vecino</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Optic neuropathy in methylmalonic acidemia: the role of neuroprotection.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2010</year>
                <volume>33</volume>
                <supplement>Suppl 3</supplement>
                <fpage>S199</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">20449661</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.quadros.2010.3033">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quadros</surname>
                    <given-names>EV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeira</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320.</article-title>
                <source>Mol Cancer Ther.</source>
                <year>2010</year>
                <volume>9</volume>
                <fpage>3033</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20858723</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.radmanesh.2008.1054">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Radmanesh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaman</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghanaati</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molaei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zamani</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Methylmalonic acidemia: brain imaging findings in 52 children and a review of the literature.</article-title>
                <source>Pediatr Radiol.</source>
                <year>2008</year>
                <volume>38</volume>
                <fpage>1054</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">18636250</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.raval.2015.839">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raval</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merideth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Methylmalonic acidemia (MMA) in pregnancy: a case series and literature review.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2015</year>
                <volume>38</volume>
                <fpage>839</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">25567501</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.rutsch.2009.234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rutsch</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gailus</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miousse</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagn&#x000e9;</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toliat</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittkampf</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharifi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robenek</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marquardt</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;hne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasnier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism.</article-title>
                <source>Nature Genet.</source>
                <volume>41</volume>
                <fpage>234</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19136951</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.ruzkova.2015.807">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ruzkova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weingarten</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedhoff</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gavrilov</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprung</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Anesthesia and organic aciduria: is the use of lactated Ringer's solution absolutely contraindicated?</article-title>
                <source>Paediatr Anaesth.</source>
                <year>2015</year>
                <volume>25</volume>
                <fpage>807</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">25943188</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.sakamoto.2007.48">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takayanagi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Mutation and haplotype analyses of the MUT gene in Japanese patients with methylmalonic acidemia.</article-title>
                <source>J Hum Genet.</source>
                <year>2007</year>
                <volume>52</volume>
                <fpage>48</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">17075691</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.saridakis.2004.23646">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saridakis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yakunin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anandakumar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennycooke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheung</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lew</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanishvili</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joachimiak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arrowsmith</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christendat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The structural basis for methylmalonic aciduria. The crystal structure of archaeal ATP:cobalamin adenosyltransferase.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>23646</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">15044458</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.sass.2012.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shield</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garg</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>LD</given-names>
                  </name>
                </person-group>
                <article-title>3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>437</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">21863277</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.schwab.2006.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwab</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauer</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okun</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijtmans</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodenburg</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Heuvel</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dr&#x000f6;se</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brandt</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ter Laak</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins.</article-title>
                <source>Biochem J</source>
                <volume>398</volume>
                <fpage>107</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16686602</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.schwartz.2009.629">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mu&#x000f1;oz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mak</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaskel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warady</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furth</surname>
                    <given-names>SL</given-names>
                  </name>
                </person-group>
                <article-title>New equations to estimate GFR in children with CKD.</article-title>
                <source>J Am Soc Nephrol.</source>
                <year>2009</year>
                <volume>20</volume>
                <fpage>629</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">19158356</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.s_nac.2012.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>S&#x000e9;nac</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sysol</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene delivery.</article-title>
                <source>Gene Ther.</source>
                <year>2012</year>
                <volume>19</volume>
                <fpage>385</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">21776024</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.sewell.1996.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sewell</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poets</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Degen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;ss</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pontz</surname>
                    <given-names>BF</given-names>
                  </name>
                </person-group>
                <article-title>The spectrum of free neuraminic acid storage disease in childhood: clinical, morphological and biochemical observations in three non-Finnish patients.</article-title>
                <source>Am J Med Genet.</source>
                <year>1996</year>
                <volume>63</volume>
                <fpage>203</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8723111</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.shapira.1991.80">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shapira</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledley</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>HL</given-names>
                  </name>
                </person-group>
                <article-title>Ketoacidotic crisis as a presentation of mild ("benign") methylmalonic acidemia.</article-title>
                <source>J Pediatr.</source>
                <year>1991</year>
                <month>Jul</month>
                <volume>119</volume>
                <issue>1 Pt 1</issue>
                <fpage>80</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">2066863</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.shigematsu.2002.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shigematsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hata</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sudo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan.</article-title>
                <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>
                <volume>776</volume>
                <fpage>39</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">12127323</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.sloan.2011.883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrillo-Carrasco</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandrasekaran</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sysol</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sapp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorward</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizing</surname>
                    <given-names>M</given-names>
                  </name>
                  <collab>NIH Intramural Sequencing Center Group</collab>
                </person-group>
                <article-title>Barshop BA, Berry SA, James PM, Champaigne NL, de Lonlay P, Valayannopoulos V, Geschwind MD, Gavrilov DK, Nyhan WL, Biesecker LG, Venditti CP. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria.</article-title>
                <source>Nat Genet.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>883</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21841779</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.sloan.2015.1346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <article-title>Liver or combined liver-kidney transplantation for patients with isolated methylmalonic acidemia: who and when?</article-title>
                <source>J Pediatr.</source>
                <year>2015</year>
                <volume>166</volume>
                <fpage>1346</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">25882873</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.sniderman.1999.675">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sniderman</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giguere</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auray-Blais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemieux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laframboise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treacy</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program.</article-title>
                <source>J Pediatr</source>
                <volume>134</volume>
                <fpage>675</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10356133</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.snyderman.1972.925">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Snyderman</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sansaricq</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phansalkar</surname>
                    <given-names>SV</given-names>
                  </name>
                </person-group>
                <article-title>The use of neomycin in the treatment of methylmalonic aciduria.</article-title>
                <source>Pediatrics.</source>
                <year>1972</year>
                <month>Dec</month>
                <volume>50</volume>
                <issue>6</issue>
                <fpage>925</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">4636459</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.spada.2015.1173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvo</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peruzzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dell'Olio</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romagnoli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porta</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Liver transplantation in severe methylmalonic acidemia: The sooner, the better.</article-title>
                <source>J Pediatr.</source>
                <year>2015</year>
                <volume>167</volume>
                <fpage>1173</fpage>
                <pub-id pub-id-type="pmid">26362094</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.stokke.1967.313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stokke</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eldjarn</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norum</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steen-Johnsen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halvorsen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1967</year>
                <article-title>Methylmalonic acidemia: a new inborn error of metabolism which may cause fatal acidosis in the neonatal period.</article-title>
                <source>Scand J Clin Lab Invest</source>
                <volume>20</volume>
                <fpage>313</fpage>
                <lpage>28</lpage>
              </element-citation>
            </ref>
            <ref id="mma.REF.str_mme.1995.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Str&#x000f8;mme</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stokke</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jellum</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skjeldal</surname>
                    <given-names>OH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Atypical methylmalonic aciduria with progressive encephalopathy, microcephaly and cataract in two siblings--a new recessive syndrome?</article-title>
                <source>Clin Genet</source>
                <volume>48</volume>
                <fpage>1</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">7586637</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.stucki.2012.1410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stucki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>1410</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22156578</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.suormala.2004.42742">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zavadakova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koch</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berghauser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wraith</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewell</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herwig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>42742</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15292234</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.therrell.2014.14">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Therrell</surname>
                    <given-names>BL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Lloyd-Puryear</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camp</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>MY</given-names>
                  </name>
                </person-group>
                <article-title>Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2014</year>
                <volume>113</volume>
                <fpage>14</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">25085281</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.traber.2011.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Traber</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangalu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donath</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landau</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Subacute bilateral visual loss in methylmalonic acidemia.</article-title>
                <source>J Neuroophthalmol.</source>
                <year>2011</year>
                <volume>31</volume>
                <fpage>344</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21873889</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.treacy.1996.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Treacy</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbour</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chessex</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasprzak</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casey</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamer</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scriver</surname>
                    <given-names>CR</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Glutathione deficiency as a complication of methylmalonic acidemia: response to high doses of ascorbate.</article-title>
                <source>J Pediatr</source>
                <volume>129</volume>
                <fpage>445</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8804337</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.tuchman.2008.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tuchman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldovic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daikhin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horyn</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissim</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissim</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yudkoff</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.</article-title>
                <source>Pediatr Res.</source>
                <year>2008</year>
                <volume>64</volume>
                <fpage>213</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18414145</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.van_calcar.1998.729">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Calcar</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>CO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyne</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banerjee</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sollinger</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieselbach</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolff</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Renal transplantation in a patient with methylmalonic acidaemia.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>21</volume>
                <fpage>729</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">9819702</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.van_der_meer.1994.903">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Meer</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poggi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnefont</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hubert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depondt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapoport</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charpentier</surname>
                    <given-names>C</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1994</year>
                <article-title>Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia.</article-title>
                <source>J Pediatr</source>
                <volume>125</volume>
                <fpage>903</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">7996362</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.van_der_meer.1990.923">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Meer</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spaapen</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakobs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleijer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wendel</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal treatment of a patient with vitamin B12-responsive methylmalonic acidemia.</article-title>
                <source>J Pediatr.</source>
                <year>1990</year>
                <volume>117</volume>
                <fpage>923</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">2246694</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.van_t_hoff.1998.1043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van 't Hoff</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mistry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rolles</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Combined liver-kidney transplantation in methylmalonic acidemia.</article-title>
                <source>J Pediatr</source>
                <volume>132</volume>
                <fpage>1043</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9627602</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.vant_hoff.1999.s70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van't Hoff</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKiernan</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                </person-group>
                <article-title>Liver transplantation for methylmalonic acidaemia.</article-title>
                <source>Eur J Pediatr.</source>
                <year>1999</year>
                <volume>158</volume>
                <supplement>Suppl 2</supplement>
                <fpage>S70</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10603103</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.vernon.2014.899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vernon</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperati</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poretti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valle</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>A detailed analysis of methylmalonic acid kinetics during hemodialysis and after combined liver/kidney transplantation in a patient with mut (0) methylmalonic acidemia.</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2014</year>
                <volume>37</volume>
                <fpage>899</fpage>
                <lpage>907</lpage>
                <pub-id pub-id-type="pmid">24961826</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.walter.1989.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michalski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barratt</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dillon</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Chronic renal failure in methylmalonic acidaemia.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>148</volume>
                <fpage>344</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">2707280</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.wasserstein.1999.788">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wasserstein</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaddipati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snyderman</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eddleman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sansaricq</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Successful pregnancy in severe methylmalonic acidaemia.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>22</volume>
                <fpage>788</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">10518278</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.williams.2009.929">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>ZR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurley</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altiparmak</surname>
                    <given-names>UE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldon</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eggenberger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mejico</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Late onset optic neuropathy in methylmalonic and propionic acidemia.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>147</volume>
                <fpage>929</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">19243738</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.wong.1992.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lau</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholls</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>MY</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Immunodeficiency in methylmalonic acidaemia.</article-title>
                <source>J Paediatr Child Health</source>
                <volume>28</volume>
                <fpage>180</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">1562372</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.worgan.2006.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Worgan</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niles</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirone</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sammak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepage</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Spectrum of mutations in mut methylmalonic academia and identification of a common Hispanic mutation and haplotype.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>31</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">16281286</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.yang.2004.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsubara</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kure</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takayanagi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iinuma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohura</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutation analysis of the MMAA and MMAB genes in Japanese patients with vitamin B(12)-responsive methylmalonic acidemia: identification of a prevalent MMAA mutation.</article-title>
                <source>Mol Genet Metab</source>
                <volume>82</volume>
                <fpage>329</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">15308131</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.yano.2003.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moseley</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guedalia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boles</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Infantile mitochondrial DNA depletion syndrome associated with methylmalonic aciduria and 3-methylcrotonyl-CoA and propionyl-CoA carboxylase deficiencies in two unrelated patients: a new phenotype of mtDNA depletion syndrome.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>26</volume>
                <fpage>481</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14518828</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.yu.2013.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scharer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brebner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quintana</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achilly</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manoli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coughlin</surname>
                    <given-names>CR</given-names>
                    <suffix>2nd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Geiger</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneck</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suormala</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hove</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumgartner</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenblatt</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaikh</surname>
                    <given-names>TH</given-names>
                  </name>
                </person-group>
                <article-title>An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2013</year>
                <volume>93</volume>
                <fpage>506</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">24011988</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.zsengell_r.2014.2139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zsengell&#x000e9;r</surname>
                    <given-names>ZK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aljinovic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teot</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodig</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sloan</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venditti</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney.</article-title>
                <source>Pediatr Nephrol.</source>
                <year>2014</year>
                <volume>29</volume>
                <fpage>2139</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">24865477</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.zwickler.2012.797">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zwickler</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haege</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riderer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;rster</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;lker</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative?</article-title>
                <source>J Inherit Metab Dis.</source>
                <year>2012</year>
                <volume>35</volume>
                <fpage>797</fpage>
                <lpage>806</lpage>
                <pub-id pub-id-type="pmid">22249333</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mma.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="mma.Suggested_Reading.reflist0">
            <ref id="mma.REF.junyent.2009.686">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Junyent</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parnell</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>YC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnett</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabagambe</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straka</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Province</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borecki</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ordov&#x000e1;s</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study.</article-title>
                <source>Am J Clin Nutr.</source>
                <year>2009</year>
                <volume>90</volume>
                <fpage>686</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">19605566</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.par_.2009.142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Par&#x000e9;</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chasman</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zee</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;larstig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seedorf</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watkins</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamsten</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miletich</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridker</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <article-title>Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study.</article-title>
                <source>Circ Cardiovasc Genet.</source>
                <year>2009</year>
                <volume>2</volume>
                <fpage>142</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">20031578</pub-id>
              </element-citation>
            </ref>
            <ref id="mma.REF.willer.2008.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Willer</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanna</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>AU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scuteri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnycastle</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heath</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timpson</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Najjar</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stringham</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strait</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duren</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maschio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busonero</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albai</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morken</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narisu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parish</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meneton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hercberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelenika</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheet</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sundvall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagaraja</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebrahim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawlor</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Shlomo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davey-Smith</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shuldiner</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergman</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuomilehto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lakatta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lathrop</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boehnke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlessinger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohlke</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abecasis</surname>
                    <given-names>GR</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Newly identified loci that influence lipid concentrations and risk of coronary artery disease.</article-title>
                <source>Nat Genet.</source>
                <volume>40</volume>
                <fpage>161</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18193043</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mma.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mma.Author_Notes">
          <title>Author Notes</title>
          <p>Dr Manoli is a pediatrician and clinical and biochemical geneticist. She is a staff clinician at the Organic Acid Research Unit of the National Human Genome Research Institute, at the National Institutes of Health.</p>
          <p>Dr Venditti is a pediatrician and clinical and biochemical geneticist. He is the director of the Organic Acid Disorder Research Unit at the National Human Genome Research Institute and an attending physician at the National Institutes of Health Clinical Center.</p>
        </sec>
        <sec id="mma.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>1 December 2016 (cpv) Revision: Molecular Genetics: <italic toggle="yes">MMAB</italic> and <italic toggle="yes">MUT</italic></p>
            </list-item>
            <list-item>
              <p>7 January 2016 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 September 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>18 January 2007 (cd) Revision: testing for mutations in <italic toggle="yes">MMAA</italic> and <italic toggle="yes">MMAB</italic> clinically available</p>
            </list-item>
            <list-item>
              <p>16 August 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>11 May 2004 (cpv) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> 'Isolated Methylmalonic Acidemia' is in the public domain in the United States of America.</p>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="mma.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Major pathway of the conversion of propionyl-CoA into succinyl-CoA. The biotin-dependent enzyme propionyl-CoA carboxylase converts propionyl-CoA into D-methylmalonyl-CoA, which is then racemized into L-methylmalonyl-CoA and isomerized into succinyl-CoA, a Krebs cycle intermediate. The L-methylmalonyl-CoA mutase reaction requires adenosylcobalamin, an activated form of vitamin B<sub>12</sub>. The pathway of cellular processing of cobalamin (OH-Cbl) in the formation of adenosyl- (AdoCbl) and methylcobalamin (MeCbl) is depicted. Adenosyl-cobalamin is the cofactor of the methylmalonyl-CoA mutase reaction; methylcobalamin is the cofactor of the methionine synthase reaction. The color-coded boxes around the cobalamin-processing enzymes indicate their role in causing: (1) isolated AdoCbl deficiency and associated increase in MMA (blue); (2) isolated MeCbl deficiency and hyperhomocysteinemia (green); (3) both cofactor deficiencies causing elevations in MMA and homocysteine (purple). Note: The light blue striped boxes indicate the enzymes (and the genes encoding them) that are deficient in different disorders in which isolated methylmalonic acidemia occurs: epimerase deficiency (<italic toggle="yes">MCEE</italic>) and succinate-CoA ligase deficiency (<italic toggle="yes">SUCLA2/SUCLG1</italic>), combined malonic and methylmalonic acidemia (<italic toggle="yes">ACSF3</italic>), and methylmalonyl-semialdehyde dehydrogenase deficiency (<italic toggle="yes">ALDH6A1</italic>). The light purple striped box indicates <italic toggle="yes">cblX</italic> deficiency (<italic toggle="yes">HCFC1</italic>), the only X-linked disorder in this pathway. The genes (and the enzymatic subtypes) associated with isolated methylmalonic acidemia included in this <italic toggle="yes">GeneReview</italic> are:<italic toggle="yes">MUT</italic> (<italic toggle="yes">mut<sup>0</sup>, mut<sup>&#x02013;</sup></italic>)<italic toggle="yes">MMAA</italic> (<italic toggle="yes">cblA</italic>)<italic toggle="yes">MMAB</italic> (<italic toggle="yes">cblB</italic>)<italic toggle="yes">MMADHC</italic> (<italic toggle="yes">cblD</italic> variant 2)<italic toggle="yes">MCEE</italic>
Isolated methylmalonic acidemia caused by mutation of <italic toggle="yes">SUCLA2</italic> and <italic toggle="yes">SUCLG1</italic> is discussed in <related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Mild Methylmalonic Aciduria</related-object> and <related-object link-type="booklink" source-id="gene" document-id="suclg1-mtddepl" document-type="chapter"><italic toggle="yes">SUCLG1</italic>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</related-object>, respecitvely.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mma-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="mma.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>An algorithm of conditions to be considered in the differential diagnosis of elevated serum or urine methylmalonic acid detected either during the follow up of an increased propionylcarnitine (C3) on newborn screening or a positive urine organic acid screen in a symptomatic individual. The algorithm includes disorders that can present after the newborn period.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mma-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
